RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | adenocarcinoma |
|
Accession: | DOID:299
|
browse the term
|
Definition: | A malignant epithelial tumor with a glandular organization. |
Synonyms: | exact_synonym: | Basal Cell Adenocarcinoma; Cribriform Carcinoma; adenocarcinomas; basal cell adenocarcinomas; cribriform carcinomas; oxyphilic adenocarcinoma; oxyphilic adenocarcinomas |
| primary_id: | MESH:D000230 |
| alt_id: | RDO:0002068 |
| xref: | NCI:C2852 |
For additional species annotation, visit the
Alliance of Genome Resources.
|
|
|
|
G |
Abl1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472143 |
|
NCBI chr 3:10,041,820...10,145,076
Ensembl chr 3:10,041,826...10,144,388
|
|
G |
Ace |
angiotensin I converting enzyme |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr10:94,170,766...94,213,831
Ensembl chr10:94,170,766...94,187,822
|
|
G |
Alox12b |
arachidonate 12-lipoxygenase, 12R type |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30258081 |
|
NCBI chr10:55,744,646...55,756,524
Ensembl chr10:55,744,588...55,756,566
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30258081 |
|
NCBI chr 4:148,398,004...148,446,308
Ensembl chr 4:148,398,892...148,446,303
|
|
G |
Angpt2 |
angiopoietin 2 |
|
IEP |
protein:increased expression:cerebrum, blood vessels (rat) |
RGD |
PMID:10373119 |
RGD:2314294 |
NCBI chr16:75,966,480...76,016,147
Ensembl chr16:75,966,352...76,016,195
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO |
DNA:frameshift mutations, nonsense mutations:exon:multiple (human) CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9111214 PMID:15639718, PMID:11677205 |
RGD:2317202 |
NCBI chr18:27,011,710...27,106,323
Ensembl chr18:27,047,382...27,105,531
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr 8:50,525,091...50,526,875
Ensembl chr 8:50,525,091...50,526,875
|
|
G |
Apoe |
apolipoprotein E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20430468 |
|
NCBI chr 1:80,612,894...80,616,820
Ensembl chr 1:80,612,895...80,617,057
|
|
G |
Arid1a |
AT-rich interaction domain 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22484628 |
|
NCBI chr 5:151,904,687...151,977,973
Ensembl chr 5:151,904,684...151,977,636
|
|
G |
Azgp1 |
alpha-2-glycoprotein 1, zinc-binding |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18978557 |
|
NCBI chr12:19,196,565...19,203,094
Ensembl chr12:19,196,611...19,202,647
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472143 |
|
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26432044 |
|
NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
|
|
G |
Car1 |
carbonic anhydrase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr 2:88,185,204...88,227,486
Ensembl chr 2:88,217,188...88,227,479
|
|
G |
Car2 |
carbonic anhydrase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr 2:88,097,740...88,112,868
Ensembl chr 2:88,097,720...88,113,029
|
|
G |
Casp8 |
caspase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472143 |
|
NCBI chr 9:65,614,142...65,662,624
Ensembl chr 9:65,614,142...65,662,106
|
|
G |
Ccn2 |
cellular communication network factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr 1:21,851,657...21,854,773
Ensembl chr 1:21,851,660...21,854,773
|
|
G |
Ccnd1 |
cyclin D1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26432044 |
|
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
|
|
G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr 1:216,661,067...216,663,791
Ensembl chr 1:216,661,080...216,663,721
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20135361 |
|
NCBI chr 5:107,823,323...107,832,405
Ensembl chr 5:107,823,330...107,841,175
|
|
G |
Ceacam1 |
CEA cell adhesion molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr 1:82,327,955...82,344,345
Ensembl chr 1:82,327,955...82,344,345
|
|
G |
Ckb |
creatine kinase B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr 6:136,142,956...136,145,838
Ensembl chr 6:136,142,956...136,145,837
|
|
G |
Ctnnb1 |
catenin beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10965019 PMID:14507667 PMID:15459021 |
|
NCBI chr 8:129,601,511...129,628,378
Ensembl chr 8:129,617,812...129,627,372
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472143 |
|
NCBI chr 8:58,744,849...58,772,408
Ensembl chr 8:58,744,849...58,772,408
|
|
G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18059332 |
|
NCBI chr 1:256,382,861...256,386,729
Ensembl chr 1:256,382,791...256,386,729
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16142352 |
|
NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
|
|
G |
Cyp7b1 |
cytochrome P450 family 7 subfamily B member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17639508 |
|
NCBI chr 2:102,701,903...102,871,257
Ensembl chr 2:102,701,903...102,871,257
|
|
G |
Dapk1 |
death associated protein kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15172992 |
|
NCBI chr17:4,297,038...4,454,941
Ensembl chr17:4,297,224...4,454,778
|
|
G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr20:3,553,430...3,574,959
Ensembl chr20:3,552,929...3,575,780
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17571247 |
|
NCBI chr 8:21,922,515...21,968,495
Ensembl chr 8:21,922,515...21,968,495
|
|
G |
Eef2 |
eukaryotic translation elongation factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21554491 |
|
NCBI chr 7:11,401,501...11,406,771
Ensembl chr 7:11,401,501...11,406,771
|
|
G |
Efemp1 |
EGF containing fibulin extracellular matrix protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17671114 |
|
NCBI chr14:113,202,382...113,294,993
Ensembl chr14:113,202,419...113,295,014
|
|
G |
Egf |
epidermal growth factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23064031 |
|
NCBI chr 2:68,820,616...68,895,537
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:2523869 PMID:20934974 PMID:21541241 PMID:22042947 PMID:27720938 |
|
NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
|
|
G |
Eno1 |
enolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr 5:167,288,223...167,299,610
Ensembl chr 5:167,288,223...167,299,609
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21673877 PMID:22042947 |
|
NCBI chr10:86,367,596...86,391,728
Ensembl chr10:86,367,596...86,391,728
|
|
G |
Esr1 |
estrogen receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15639718 PMID:20458558 |
|
NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
|
|
G |
Esr2 |
estrogen receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17639508 |
|
NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251
|
|
G |
Fat4 |
FAT atypical cadherin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22484628 |
|
NCBI chr 2:125,751,818...125,879,398
Ensembl chr 2:125,752,130...125,879,387
|
|
G |
Fen1 |
flap structure-specific endonuclease 1 |
susceptibility |
ISO |
|
RGD |
PMID:12119409 |
RGD:737746 |
NCBI chr 1:226,251,516...226,256,160
Ensembl chr 1:226,251,518...226,255,886
|
|
G |
Fgf9 |
fibroblast growth factor 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20464547 |
|
NCBI chr15:38,341,657...38,386,945
Ensembl chr15:38,341,089...38,387,316
|
|
G |
Gast |
gastrin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:3952654 |
|
NCBI chr10:88,245,532...88,248,485
Ensembl chr10:88,245,532...88,248,484
|
|
G |
Ghrl |
ghrelin and obestatin prepropeptide |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472143 |
|
NCBI chr 4:145,674,157...145,678,066
Ensembl chr 4:145,674,157...145,678,066
|
|
G |
Gkn1 |
gastrokine 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr 4:119,143,070...119,148,358
Ensembl chr 4:119,143,070...119,148,358
|
|
G |
Gmpr2 |
guanosine monophosphate reductase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr15:34,352,857...34,362,074
Ensembl chr15:34,352,914...34,362,032
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr10:40,247,436...40,255,423
Ensembl chr10:40,247,436...40,255,422
|
|
G |
Grb7 |
growth factor receptor bound protein 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr10:86,393,186...86,408,893
Ensembl chr10:86,399,827...86,409,348
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
susceptibility |
ISO |
colon and stomach;protein:decreased activity:liver (human) |
RGD |
PMID:1988177 |
RGD:7488952 |
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
|
|
G |
Hmox1 |
heme oxygenase 1 |
susceptibility |
ISO |
Lung Adenocarcinoma |
RGD |
PMID:15688187 |
RGD:1601607 |
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
|
|
G |
Hoxa10 |
homeobox A10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21670700 |
|
NCBI chr 4:82,285,940...82,295,892
Ensembl chr 4:82,285,528...82,295,470
|
|
G |
Hrh4 |
histamine receptor H4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363581 |
|
NCBI chr18:4,365,429...4,382,599
Ensembl chr18:4,365,429...4,382,599
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr 8:44,989,401...44,993,261
Ensembl chr 8:44,990,014...44,993,179
|
|
G |
Hspd1 |
heat shock protein family D (Hsp60) member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr 9:61,680,529...61,691,202
Ensembl chr 9:61,680,530...61,690,956
|
|
G |
Id3 |
inhibitor of DNA binding 3, HLH protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr 5:154,489,603...154,491,172
Ensembl chr 5:154,489,590...154,491,223
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19028472 |
|
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
|
|
G |
Kcnq1 |
potassium voltage-gated channel subfamily Q member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23975432 |
|
NCBI chr 1:216,293,087...216,630,339
Ensembl chr 1:216,293,087...216,630,339
|
|
G |
Kdr |
kinase insert domain receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472143 |
|
NCBI chr14:34,727,677...34,787,127
Ensembl chr14:34,727,623...34,787,183
|
|
G |
Kmt2a |
lysine methyltransferase 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22484628 |
|
NCBI chr 8:49,110,407...49,185,872
Ensembl chr 8:49,114,990...49,158,971
|
|
G |
Kmt2c |
lysine methyltransferase 2C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22484628 |
|
NCBI chr 4:82,506...109,986 NCBI chr 4:6,083,650...6,294,413
Ensembl chr 4:6,083,736...6,292,516
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11745231 PMID:16247444 PMID:20101149 |
|
NCBI chr 4:179,482,562...179,515,483
Ensembl chr 4:179,486,105...179,515,558
|
|
G |
Krt20 |
keratin 20 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr10:87,342,514...87,351,045
Ensembl chr10:87,342,619...87,351,045
|
|
G |
Krt8 |
keratin 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr 7:143,596,511...143,603,745
Ensembl chr 7:143,596,511...143,603,803
|
|
G |
Lta4h |
leukotriene A4 hydrolase |
|
IEP |
protein:increased expression:esophagus (rat) |
RGD |
PMID:12865451 |
RGD:2316606 |
NCBI chr 7:34,288,333...34,320,243
Ensembl chr 7:34,288,365...34,320,235
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20934974 PMID:22042947 |
|
NCBI chr 4:44,747,467...44,854,628
Ensembl chr 4:44,774,741...44,852,665
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19028472 |
|
NCBI chr 1:207,993,895...208,020,454
Ensembl chr 1:207,993,895...208,020,454
|
|
G |
Mmp14 |
matrix metallopeptidase 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472143 |
|
NCBI chr15:33,074,441...33,083,666
Ensembl chr15:33,074,441...33,083,655
|
|
G |
Mpp1 |
membrane palmitoylated protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr 1:148,450,213...148,458,945
|
|
G |
Msln |
mesothelin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11751476 |
|
NCBI chr10:15,119,700...15,129,129
Ensembl chr10:15,119,663...15,125,408
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18058806 |
|
NCBI chr 5:165,263,813...165,373,967
Ensembl chr 5:165,263,800...165,373,967
|
|
G |
Muc2 |
mucin 2, oligomeric mucus/gel-forming |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12468628 |
|
NCBI chr 1:214,663,929...214,693,197
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26432044 |
|
NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
|
|
G |
Nat1 |
N-acetyltransferase 1 |
susceptibility |
ISO |
associated with lung neoplasm; DNA:polymorphis: : |
RGD |
PMID:11266080 |
RGD:5131865 |
NCBI chr16:23,970,742...23,991,573
Ensembl chr16:23,970,743...23,991,573
|
|
G |
Ncoa3 |
nuclear receptor coactivator 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20852035 |
|
NCBI chr 3:162,692,176...162,788,582
Ensembl chr 3:162,692,185...162,787,548
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19028472 |
|
NCBI chr 2:240,773,520...240,890,053
Ensembl chr 2:240,773,456...240,866,689
|
|
G |
Nos3 |
nitric oxide synthase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472143 |
|
NCBI chr 4:7,321,908...7,342,404
Ensembl chr 4:7,320,668...7,342,410
|
|
G |
Nppa |
natriuretic peptide A |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:18225537 |
|
NCBI chr 5:164,808,407...164,809,716
Ensembl chr 5:164,808,323...164,809,705
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21977915 |
|
NCBI chr11:65,022,100...65,058,546
Ensembl chr11:65,022,100...65,058,545
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19336973 |
|
NCBI chr 4:145,282,828...145,289,367
Ensembl chr 4:145,282,797...145,289,326
|
|
G |
Pawr |
pro-apoptotic WT1 regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15877079 |
|
NCBI chr 7:51,273,764...51,353,700
Ensembl chr 7:51,273,771...51,353,068
|
|
G |
Pcna |
proliferating cell nuclear antigen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19028472 |
|
NCBI chr 3:124,880,698...124,884,570
Ensembl chr 3:124,880,698...124,884,570
|
|
G |
Pgam1 |
phosphoglycerate mutase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr 1:261,158,204...261,165,814
Ensembl chr 1:261,158,261...261,165,808
|
|
G |
Pgr |
progesterone receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15639718 |
|
NCBI chr 8:7,128,656...7,187,796
Ensembl chr 8:7,128,656...7,187,796
|
|
G |
Phb |
prohibitin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr10:83,476,107...83,488,878
Ensembl chr10:83,476,107...83,488,878
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22484628 |
|
NCBI chr 2:118,831,350...118,861,456
Ensembl chr 2:118,831,350...118,861,454
|
|
G |
Plau |
plasminogen activator, urokinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10467400 |
|
NCBI chr15:3,644,296...3,650,765
Ensembl chr15:3,644,769...3,650,819
|
|
G |
Plce1 |
phospholipase C, epsilon 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20729852 |
|
NCBI chr 1:257,156,023...257,465,440
Ensembl chr 1:257,157,264...257,466,064
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11034103 |
|
NCBI chr 4:147,274,055...147,399,383
Ensembl chr 4:147,274,107...147,399,380
|
|
G |
Prkd1 |
protein kinase D1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25240283 |
|
NCBI chr 6:71,035,017...71,349,531
Ensembl chr 6:71,035,332...71,349,249
|
|
G |
Prl |
prolactin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:6280079 |
|
NCBI chr17:39,814,236...39,824,299
Ensembl chr17:39,814,244...39,824,299
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17909629 |
|
NCBI chr 1:251,421,814...251,487,634
Ensembl chr 1:251,421,596...251,487,832
|
|
G |
Ptger1 |
prostaglandin E receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11751431 |
|
NCBI chr19:24,799,422...24,803,373
Ensembl chr19:24,800,072...24,803,373
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
IMP ISO |
associated with Esophageal Neoplasms CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10485483 PMID:16820089, PMID:17675820 |
RGD:1642603 |
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
|
|
G |
Ptpn11 |
protein tyrosine phosphatase, non-receptor type 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26432044 |
|
NCBI chr12:40,895,515...40,955,999
Ensembl chr12:40,895,515...40,955,999
|
|
G |
Pycard |
PYD and CARD domain containing |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16778195 |
|
NCBI chr 1:199,438,029...199,439,062
Ensembl chr 1:199,437,832...199,439,210
|
|
G |
Ramp2 |
receptor activity modifying protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17671114 |
|
NCBI chr10:89,166,170...89,168,962
Ensembl chr10:89,166,890...89,168,965
|
|
G |
Rarb |
retinoic acid receptor, beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14656941 |
|
NCBI chr15:9,915,223...10,262,599
Ensembl chr15:10,120,206...10,262,599
|
|
G |
Rassf1 |
Ras association domain family member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15639718 |
|
NCBI chr 8:116,307,149...116,318,289
Ensembl chr 8:116,307,141...116,318,289
|
|
G |
Robo1 |
roundabout guidance receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17671114 |
|
NCBI chr11:9,079,291...10,146,302
Ensembl chr11:9,642,365...10,143,317
|
|
G |
Runx3 |
RUNX family transcription factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr 5:153,507,093...153,531,137
Ensembl chr 5:153,507,093...153,531,137
|
|
G |
Selenbp1 |
selenium binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14991897 PMID:15378696 |
|
NCBI chr 2:196,105,592...196,146,474
Ensembl chr 2:196,105,569...196,113,149
|
|
G |
Serpina1 |
serpin family A member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr 6:127,610,241...127,632,265
Ensembl chr 6:127,610,243...127,632,265
|
|
G |
Smarcc1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr 8:118,206,678...118,326,264
Ensembl chr 8:118,206,698...118,325,537
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12907644 |
|
NCBI chr 1:47,914,757...47,921,587
Ensembl chr 1:47,914,759...47,921,587
|
|
G |
Sphk1 |
sphingosine kinase 1 |
|
IEP |
protein, mRNA:increased expression:colon mucosa (rat) |
RGD |
PMID:16319132 |
RGD:2311380 |
NCBI chr10:105,498,728...105,504,401
Ensembl chr10:105,498,728...105,504,393
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20495387 PMID:21552421 |
|
NCBI chr14:6,673,686...6,679,965
Ensembl chr14:6,673,686...6,679,901
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19028472 PMID:26432044 |
|
NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233
|
|
G |
Stat5a |
signal transducer and activator of transcription 5A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20235097 PMID:21552421 |
|
NCBI chr10:88,764,732...88,789,060
Ensembl chr10:88,764,732...88,789,057
|
|
G |
Stk11 |
serine/threonine kinase 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17676035 |
|
NCBI chr 7:12,440,751...12,457,513
Ensembl chr 7:12,440,751...12,457,513
|
|
G |
Strap |
serine/threonine kinase receptor associated protein |
|
ISO |
|
RGD |
PMID:16778189 |
RGD:1581429 |
NCBI chr 4:171,730,629...171,744,877
Ensembl chr 4:171,730,635...171,745,377
|
|
G |
Sycp1 |
synaptonemal complex protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14991579 |
|
NCBI chr 2:205,274,766...205,426,869
Ensembl chr 2:205,274,769...205,426,869
|
|
G |
Tcf7l2 |
transcription factor 7 like 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21892161 |
|
NCBI chr 1:276,686,911...276,730,517
Ensembl chr 1:276,659,542...276,730,514 Ensembl chr 1:276,659,542...276,730,514
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17418594 |
|
NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:1733439 PMID:19028472 |
|
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Tnfrsf10b |
TNF receptor superfamily member 10b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472143 |
|
NCBI chr15:51,433,853...51,464,215
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic ClinVar Annotator: match by term: Adenocarcinoma |
CTD ClinVar |
PMID:1565143 PMID:1591732 PMID:7565304 PMID:7783166 PMID:7955072 PMID:8550239 PMID:8718514 PMID:9218725 PMID:9242456 PMID:9364015 PMID:9667734 PMID:10519380 PMID:10797276 PMID:10922393 PMID:11370630 PMID:11798837 PMID:12826609 PMID:12885464 PMID:12917626 PMID:15722483 PMID:15925506 PMID:15951970 PMID:16247444 PMID:16401470 PMID:16494995 PMID:16551709 PMID:17015838 PMID:17311302 PMID:17606709 PMID:18511570 PMID:20128691 PMID:20522432 PMID:21343334 PMID:21761402 PMID:22484628 PMID:23538418 PMID:24033266 PMID:24122735 PMID:24835218 PMID:25157968 PMID:25741868 PMID:26205489 PMID:26225655 PMID:26619011 PMID:26786923 PMID:27621308 PMID:28492532 PMID:30816478 PMID:32000721 |
|
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
G |
Tp63 |
tumor protein p63 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20871597 |
|
NCBI chr11:78,234,853...78,456,559
Ensembl chr11:78,234,800...78,456,501
|
|
G |
Tpm3 |
tropomyosin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr 2:189,423,534...189,451,340
Ensembl chr 2:189,423,559...189,451,029
|
|
G |
Tyrp1 |
tyrosinase-related protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr 5:98,387,291...98,406,083
Ensembl chr 5:98,387,291...98,406,083
|
|
G |
Ugt2b17 |
UDP glucuronosyltransferase family 2 member B17 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17416778 |
|
NCBI chr14:22,724,399...22,736,148
Ensembl chr14:22,724,070...22,825,444
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26432044 |
|
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
|
|
G |
Vti1a |
vesicle transport through interaction with t-SNAREs 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21892161 |
|
NCBI chr 1:276,310,072...276,508,635
Ensembl chr 1:276,309,927...276,490,602
|
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO |
DNA:mutations (human) |
RGD |
PMID:11891193 |
RGD:2317200 |
NCBI chr18:27,011,710...27,106,323
Ensembl chr18:27,047,382...27,105,531
|
|
|
G |
Fancf |
FA complementation group F |
disease_progression |
ISO |
DNA:hypermethylation:promoter: |
RGD |
PMID:14647419 |
RGD:11049137 |
NCBI chr 1:107,229,516...107,232,321
Ensembl chr 1:107,231,292...107,232,305
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12015757 |
|
NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
|
|
G |
Bap1 |
Brca1 associated protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231345 |
|
NCBI chr16:7,336,685...7,345,511
Ensembl chr16:7,336,685...7,345,511
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Adrenocortical carcinoma ClinVar Annotator: match by term: Adrenocortical Carcinoma |
CTD ClinVar |
PMID:12068308 PMID:14612909 PMID:14679157 PMID:14688025 PMID:17096326 PMID:17119447 PMID:17311103 PMID:18368129 PMID:18794803 PMID:19383316 PMID:19537845 PMID:19913317 PMID:20350999 PMID:20619739 PMID:21129611 PMID:22310681 PMID:23352452 PMID:23585556 PMID:24033266 PMID:25157968 PMID:26619011 PMID:28492532 PMID:29595366 |
|
NCBI chr 4:67,389,331...67,520,549
Ensembl chr 4:67,396,192...67,520,356
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24747642 |
|
NCBI chr 5:107,823,323...107,832,405
Ensembl chr 5:107,823,330...107,841,175
|
|
G |
Ctnnb1 |
catenin beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Adrenocortical carcinoma ClinVar Annotator: match by term: Adrenocortical Carcinoma |
CTD ClinVar |
PMID:9065403 PMID:9500465 PMID:9927029 PMID:10027390 PMID:10192393 PMID:10398436 PMID:10435629 PMID:10655994 PMID:11351304 PMID:11930117 PMID:11950921 PMID:12124804 PMID:15133491 PMID:23265383 PMID:24747642 PMID:24788118 PMID:25157968 PMID:26619011 PMID:26822237 |
|
NCBI chr 8:129,601,511...129,628,378
Ensembl chr 8:129,617,812...129,627,372
|
|
G |
Daxx |
death-domain associated protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24747642 |
|
NCBI chr20:5,480,103...5,485,962
Ensembl chr20:5,480,103...5,485,926
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23585556 |
|
NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
|
|
G |
Gnas |
GNAS complex locus |
|
ISO |
ClinVar Annotator: match by term: Adrenocortical Carcinoma |
ClinVar |
PMID:1594625 PMID:1944469 PMID:2549426 PMID:3720010 PMID:7739708 PMID:8766942 PMID:9626141 PMID:12727968 PMID:12970318 PMID:15126527 PMID:16507630 PMID:21835143 PMID:23536913 PMID:24855271 PMID:25157968 PMID:26619011 |
|
NCBI chr 3:172,374,957...172,434,988
Ensembl chr 3:172,374,957...172,428,483 Ensembl chr 3:172,374,957...172,428,483
|
|
G |
H3f3a |
H3.3 histone A |
|
ISO |
ClinVar Annotator: match by term: Adrenocortical Carcinoma |
ClinVar |
PMID:26619011 |
|
NCBI chr13:99,091,246...99,102,828
Ensembl chr13:99,091,763...99,101,208
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22407999 |
|
NCBI chr 1:128,924,921...129,213,816
Ensembl chr 1:128,924,966...129,206,516
|
|
G |
Igf2 |
insulin-like growth factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21521927 PMID:23417626 |
|
NCBI chr 1:215,828,102...215,839,081
Ensembl chr 1:215,828,102...215,846,911
|
|
G |
Med12 |
mediator complex subunit 12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24747642 |
|
NCBI chr X:71,174,653...71,197,812
Ensembl chr X:71,174,699...71,197,812
|
|
G |
Men1 |
menin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24747642 |
|
NCBI chr 1:221,704,394...221,710,343
Ensembl chr 1:221,704,493...221,710,331
|
|
G |
Nras |
NRAS proto-oncogene, GTPase |
|
ISO |
ClinVar Annotator: match by term: Adrenocortical Carcinoma ClinVar Annotator: match by term: Adrenocortical carcinoma |
ClinVar |
PMID:1654209 PMID:2278970 PMID:2674680 PMID:3122217 PMID:6587382 PMID:8120410 PMID:10821536 PMID:12460918 PMID:12727991 PMID:14508525 PMID:15899789 PMID:16273091 PMID:16291983 PMID:16434492 PMID:17699718 PMID:18390968 PMID:18633438 PMID:18668139 PMID:18948947 PMID:19075190 PMID:19657110 PMID:19880792 PMID:20130576 PMID:20149136 PMID:20179705 PMID:20406486 PMID:20619739 PMID:20736745 PMID:21107323 PMID:21305640 PMID:21576590 PMID:21729679 PMID:21829508 PMID:22407852 PMID:22499344 PMID:22718121 PMID:22761467 PMID:22773810 PMID:23076151 PMID:23392294 PMID:23400451 PMID:23414587 PMID:23515407 PMID:23538902 PMID:23569304 PMID:23614898 PMID:24006476 PMID:24033266 PMID:24148783 PMID:24370118 PMID:24671188 PMID:25157968 PMID:25348872 PMID:25695684 PMID:26619011 PMID:26821351 PMID:27050078 PMID:28492532 PMID:28780248 |
|
NCBI chr 2:205,553,119...205,563,716
Ensembl chr 2:205,553,163...205,560,791
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
ISO |
ClinVar Annotator: match by term: Adrenocortical Carcinoma ClinVar Annotator: match by term: Adrenocortical carcinoma |
ClinVar |
PMID:15016963 PMID:15254419 PMID:15520168 PMID:15608678 PMID:15647370 PMID:15805248 PMID:16906227 PMID:16930767 PMID:17376864 PMID:17673550 PMID:18676830 PMID:18725974 PMID:19029981 PMID:19223544 PMID:19366826 PMID:19513541 PMID:19903786 PMID:20453058 PMID:20619739 PMID:21430269 PMID:21558396 PMID:21824802 PMID:22162582 PMID:22162589 PMID:22271473 PMID:22658544 PMID:22729222 PMID:22729224 PMID:23100325 PMID:24033266 PMID:24782230 PMID:25157968 PMID:25741868 PMID:26266975 PMID:26266985 PMID:26619011 PMID:26822237 PMID:27626068 PMID:27631024 PMID:28492532 PMID:29446767 PMID:31775759 |
|
NCBI chr 2:118,831,350...118,861,456
Ensembl chr 2:118,831,350...118,861,454
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24747642 |
|
NCBI chr15:55,081,582...55,209,060
Ensembl chr15:55,083,140...55,209,342
|
|
G |
Rrm1 |
ribonucleotide reductase catalytic subunit M1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22547773 |
|
NCBI chr 1:167,538,387...167,562,688
Ensembl chr 1:167,538,263...167,562,688
|
|
G |
Sparc |
secreted protein acidic and cysteine rich |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22156929 |
|
NCBI chr10:40,742,390...40,764,232
Ensembl chr10:40,742,400...40,764,185
|
|
G |
Tert |
telomerase reverse transcriptase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24747642 |
|
NCBI chr 1:32,250,876...32,275,330
Ensembl chr 1:32,251,714...32,272,476
|
|
G |
Top2a |
DNA topoisomerase II alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23533247 |
|
NCBI chr10:86,901,467...86,930,947
Ensembl chr10:86,901,007...86,932,154
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Adrenocortical carcinoma ClinVar Annotator: match by term: Adrenocortical Carcinoma |
CTD ClinVar |
PMID:1565144 PMID:1918170 PMID:2826609 PMID:7651740 PMID:7707106 PMID:7732013 PMID:7750099 PMID:7887414 PMID:8023157 PMID:8080050 PMID:8164043 PMID:8336941 PMID:8423216 PMID:8479749 PMID:8869100 PMID:9020384 PMID:9157982 PMID:9242456 PMID:9407971 PMID:9472631 PMID:9525742 PMID:9569050 PMID:9572492 PMID:9815696 PMID:10229196 PMID:10567903 PMID:10864200 PMID:10871862 PMID:11051241 PMID:11429705 PMID:11793474 PMID:11896595 PMID:11920788 PMID:12034820 PMID:12509279 PMID:12672316 PMID:12695689 PMID:12826609 PMID:12901974 PMID:12917626 PMID:14584079 PMID:15017592 PMID:15037740 PMID:15390294 PMID:15607980 PMID:15951970 PMID:16401470 PMID:16474844 PMID:16489069 PMID:16494995 PMID:16508005 PMID:16736287 PMID:16861262 PMID:17401428 PMID:17540308 PMID:17541742 PMID:17606709 PMID:17636407 PMID:17724467 PMID:18208484 PMID:18511570 PMID:18555592 PMID:18685109 PMID:18989156 PMID:19147582 PMID:19336573 PMID:19367569 PMID:19468865 PMID:19681600 PMID:19850740 PMID:20127978 PMID:20128691 PMID:20407015 PMID:20506564 PMID:20516128 PMID:20522432 PMID:20593220 PMID:20693561 PMID:21159183 PMID:21343334 PMID:21470402 PMID:21484931 PMID:21535297 PMID:21552135 PMID:21626334 PMID:21761402 PMID:22710932 PMID:22768918 PMID:22811390 PMID:22847613 PMID:22899716 PMID:23161690 PMID:23259501 PMID:23585556 PMID:23894400 PMID:23967324 PMID:24033266 PMID:24381225 PMID:24384472 PMID:24487413 PMID:24641375 PMID:24677579 PMID:24728327 PMID:24744791 PMID:24747642 PMID:24940547 PMID:25157968 PMID:25339994 PMID:25503501 PMID:25584008 PMID:25584637 PMID:25741868 PMID:25787918 PMID:25896519 PMID:26014290 PMID:26270727 PMID:26467025 PMID:26556299 PMID:26619011 PMID:26681312 PMID:26822237 PMID:26845104 PMID:27022024 PMID:27149858 PMID:27374712 PMID:27458004 PMID:27533082 PMID:27724982 PMID:27730344 PMID:28369373 PMID:28453743 PMID:28492532 PMID:28724667 PMID:28861920 PMID:29070607 PMID:29489754 PMID:29753700 PMID:29979965 PMID:30128536 PMID:30216591 PMID:30224644 PMID:30299350 PMID:30311369 PMID:30352134 PMID:30630526 PMID:30709381 PMID:30720243 PMID:30816478 PMID:30840781 PMID:31016814 PMID:31206626 PMID:31775759 PMID:32401780 |
|
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
G |
Znrf3 |
zinc and ring finger 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24747642 |
|
NCBI chr14:85,527,099...85,586,294
|
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
ISO |
ClinVar Annotator: match by term: Hepatocellular carcinoma, adult |
ClinVar |
PMID:17611497 PMID:18256540 PMID:18392055 PMID:18504432 PMID:18611285 PMID:19418217 PMID:19487299 PMID:19853286 PMID:20233444 PMID:20453058 PMID:21464312 PMID:21512767 PMID:21793738 PMID:22538770 PMID:22610119 PMID:22722201 PMID:22722839 PMID:22980975 PMID:23237847 PMID:23348505 PMID:23700467 PMID:23728071 PMID:23934607 PMID:24190505 PMID:24657128 PMID:25157968 PMID:26619011 PMID:28492532 |
|
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO |
ClinVar Annotator: match by term: Hepatocellular carcinoma, adult |
ClinVar |
PMID:25741868 PMID:25992589 PMID:26493165 PMID:28492532 |
|
NCBI chr18:27,011,710...27,106,323
Ensembl chr18:27,047,382...27,105,531
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
ISO |
ClinVar Annotator: match by term: Hepatocellular carcinoma, adult |
ClinVar |
PMID:7780957 PMID:8521414 PMID:9185756 PMID:9324288 PMID:10491434 PMID:14508519 PMID:16234564 PMID:16896043 PMID:21462282 PMID:25157968 PMID:25741868 PMID:25780468 PMID:26225579 PMID:26467025 PMID:26619011 PMID:28492532 |
|
NCBI chr 5:107,823,323...107,832,405
Ensembl chr 5:107,823,330...107,841,175
|
|
G |
Crebbp |
CREB binding protein |
|
ISO |
ClinVar Annotator: match by term: Hepatocellular carcinoma, adult |
ClinVar |
PMID:21390126 PMID:21680795 PMID:21796119 PMID:22832583 PMID:23334668 PMID:23685749 PMID:23778141 PMID:26087898 PMID:26619011 PMID:27257180 PMID:28492532 PMID:29551561 |
|
NCBI chr10:11,590,994...11,721,039
Ensembl chr10:11,595,044...11,721,039
|
|
G |
Ctnnb1 |
catenin beta 1 |
|
ISO |
ClinVar Annotator: match by term: Hepatocellular carcinoma, adult |
ClinVar |
PMID:9065402 PMID:9065403 PMID:9294210 PMID:9500465 PMID:9927029 PMID:10027390 PMID:10192393 PMID:10391090 PMID:10398436 PMID:10435629 PMID:10655994 PMID:10666372 PMID:11351304 PMID:11930117 PMID:11950921 PMID:12124804 PMID:15133491 PMID:24788118 PMID:25157968 PMID:26619011 PMID:26822237 |
|
NCBI chr 8:129,601,511...129,628,378
Ensembl chr 8:129,617,812...129,627,372
|
|
G |
Gnas |
GNAS complex locus |
|
ISO |
ClinVar Annotator: match by term: Hepatocellular carcinoma, adult |
ClinVar |
PMID:1594625 PMID:1944469 PMID:2549426 PMID:3720010 PMID:7739708 PMID:8766942 PMID:9626141 PMID:12727968 PMID:12970318 PMID:15126527 PMID:16507630 PMID:21835143 PMID:23536913 PMID:24855271 PMID:25157968 PMID:26619011 |
|
NCBI chr 3:172,374,957...172,434,988
Ensembl chr 3:172,374,957...172,428,483 Ensembl chr 3:172,374,957...172,428,483
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
|
ISO |
ClinVar Annotator: match by term: Hepatocellular carcinoma, adult |
ClinVar |
PMID:11150980 PMID:12835555 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17211612 PMID:17384584 PMID:17412879 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19213030 PMID:19255327 PMID:19371735 PMID:19382114 PMID:19669404 PMID:19773371 PMID:20660566 PMID:20859122 PMID:20979192 PMID:21438134 PMID:21495179 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22256804 PMID:22317973 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22726224 PMID:22926243 PMID:23093928 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23751039 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24390138 PMID:24803665 PMID:25157968 PMID:25326635 PMID:25741868 PMID:25914166 PMID:26619011 PMID:27195699 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28492532 PMID:29493581 PMID:31394527 PMID:31775759 PMID:168335863 |
|
NCBI chr 1:214,178,404...214,181,841
Ensembl chr 1:214,178,407...214,181,686
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
|
ISO |
ClinVar Annotator: match by term: Hepatocellular carcinoma, adult |
ClinVar |
PMID:18772396 PMID:19657110 PMID:19798509 PMID:19818334 PMID:20946881 PMID:21352804 PMID:21446021 PMID:22160010 PMID:22397365 PMID:22417203 PMID:22898539 PMID:23558169 PMID:24606448 PMID:25043048 PMID:25157968 PMID:25741868 PMID:26619011 |
|
NCBI chr 9:71,882,108...71,911,645
Ensembl chr 9:71,882,105...71,900,044
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
|
ISO |
ClinVar Annotator: match by term: Hepatocellular carcinoma, adult |
ClinVar |
PMID:20946881 PMID:21250968 PMID:21596855 PMID:21997850 PMID:22160010 PMID:22397365 PMID:22417203 PMID:22616558 PMID:22898539 PMID:23949315 PMID:24606448 PMID:25157968 PMID:26619011 |
|
NCBI chr 1:141,874,354...141,893,674
Ensembl chr 1:141,866,283...141,893,705
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
|
ISO |
ClinVar Annotator: match by term: Hepatocellular carcinoma, adult |
ClinVar |
PMID:2278970 PMID:3122217 PMID:12460918 PMID:15696205 PMID:16361624 PMID:16434492 PMID:16618717 PMID:18316791 PMID:18794081 PMID:19075190 PMID:19114683 PMID:19679400 PMID:20921462 PMID:20921465 PMID:21228335 PMID:22407852 PMID:22722830 PMID:23325582 PMID:25157968 PMID:26619011 |
|
NCBI chr 4:179,482,562...179,515,483
Ensembl chr 4:179,486,105...179,515,558
|
|
G |
Lrrc56 |
leucine rich repeat containing 56 |
|
ISO |
ClinVar Annotator: match by term: Hepatocellular carcinoma, adult |
ClinVar |
PMID:11150980 PMID:12835555 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17211612 PMID:17384584 PMID:17412879 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19213030 PMID:19255327 PMID:19371735 PMID:19382114 PMID:19669404 PMID:19773371 PMID:20660566 PMID:20859122 PMID:20979192 PMID:21438134 PMID:21495179 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22256804 PMID:22317973 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22726224 PMID:22926243 PMID:23093928 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23751039 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24390138 PMID:24803665 PMID:25157968 PMID:25326635 PMID:25741868 PMID:25914166 PMID:26619011 PMID:27195699 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28492532 PMID:29493581 PMID:31394527 PMID:31775759 PMID:168335863 |
|
NCBI chr 1:214,182,232...214,197,184
Ensembl chr 1:214,182,830...214,197,184
|
|
G |
Nras |
NRAS proto-oncogene, GTPase |
|
ISO |
ClinVar Annotator: match by term: Hepatocellular carcinoma, adult |
ClinVar |
PMID:1654209 PMID:2278970 PMID:2674680 PMID:3122217 PMID:6587382 PMID:8120410 PMID:10821536 PMID:12460918 PMID:12727991 PMID:14508525 PMID:15899789 PMID:16273091 PMID:16291983 PMID:16434492 PMID:17699718 PMID:18390968 PMID:18633438 PMID:18668139 PMID:18948947 PMID:19075190 PMID:19657110 PMID:19880792 PMID:20130576 PMID:20149136 PMID:20179705 PMID:20406486 PMID:20619739 PMID:20736745 PMID:21107323 PMID:21305640 PMID:21576590 PMID:21729679 PMID:21829508 PMID:22407852 PMID:22499344 PMID:22718121 PMID:22761467 PMID:22773810 PMID:23076151 PMID:23392294 PMID:23400451 PMID:23414587 PMID:23515407 PMID:23538902 PMID:23569304 PMID:23614898 PMID:24006476 PMID:24033266 PMID:24148783 PMID:24370118 PMID:24671188 PMID:25157968 PMID:25348872 PMID:25695684 PMID:26619011 PMID:26821351 PMID:27050078 PMID:28492532 PMID:28780248 |
|
NCBI chr 2:205,553,119...205,563,716
Ensembl chr 2:205,553,163...205,560,791
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
ISO |
ClinVar Annotator: match by term: Hepatocellular carcinoma, adult |
ClinVar |
PMID:15016963 PMID:15254419 PMID:15520168 PMID:15608678 PMID:15647370 PMID:15805248 PMID:16906227 PMID:16930767 PMID:17376864 PMID:17673550 PMID:18676830 PMID:18725974 PMID:19029981 PMID:19223544 PMID:19366826 PMID:19513541 PMID:19903786 PMID:20453058 PMID:20619739 PMID:21430269 PMID:21558396 PMID:21824802 PMID:22162582 PMID:22162589 PMID:22209294 PMID:22271473 PMID:22357840 PMID:22658544 PMID:22729222 PMID:22729223 PMID:22729224 PMID:23066039 PMID:23100325 PMID:23408298 PMID:23888070 PMID:24033266 PMID:24265155 PMID:24559322 PMID:24782230 PMID:25157968 PMID:25741868 PMID:26266975 PMID:26266985 PMID:26619011 PMID:26822237 PMID:26851524 PMID:27626068 PMID:27631024 PMID:28492532 PMID:29446767 PMID:31775759 |
|
NCBI chr 2:118,831,350...118,861,456
Ensembl chr 2:118,831,350...118,861,454
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
ClinVar Annotator: match by term: Hepatocellular carcinoma, adult |
ClinVar |
PMID:1349102 PMID:1349175 PMID:1359493 PMID:1565143 PMID:1565144 PMID:1569604 PMID:1591732 PMID:1631137 PMID:1631151 PMID:1672732 PMID:1673792 PMID:1679237 PMID:1683921 PMID:1686725 PMID:1849234 PMID:1915267 PMID:1918170 PMID:1978757 PMID:2046748 PMID:2113594 PMID:2259385 PMID:2531845 PMID:2554494 PMID:2826609 PMID:7565304 PMID:7651740 PMID:7707106 PMID:7732013 PMID:7750099 PMID:7783166 PMID:7791795 PMID:7881428 PMID:7887414 PMID:7969167 PMID:8023157 PMID:8062826 PMID:8080050 PMID:8099841 PMID:8118819 PMID:8164043 PMID:8242631 PMID:8336941 PMID:8364550 PMID:8401536 PMID:8423216 PMID:8425176 PMID:8479749 PMID:8527048 PMID:8550239 PMID:8633021 PMID:8718514 PMID:8825920 PMID:8829627 PMID:8869100 PMID:9047394 PMID:9049183 PMID:9218725 PMID:9242456 PMID:9268986 PMID:9290701 PMID:9364015 PMID:9407971 PMID:9472631 PMID:9525742 PMID:9546439 PMID:9569050 PMID:9572492 PMID:9598730 PMID:9627118 PMID:9632751 PMID:9662334 PMID:9667734 PMID:9825943 PMID:9839505 PMID:10064694 PMID:10229196 PMID:10366100 PMID:10411893 PMID:10432928 PMID:10519380 PMID:10557074 PMID:10567903 PMID:10589545 PMID:10616528 PMID:10713666 PMID:10753186 PMID:10754498 PMID:10761705 PMID:10797439 PMID:10864200 PMID:10871862 PMID:10914716 PMID:10922393 PMID:11051239 PMID:11051241 PMID:11101847 PMID:11139324 PMID:11180592 PMID:11313981 PMID:11315715 PMID:11370630 PMID:11429705 PMID:11479205 PMID:11494139 PMID:11590071 PMID:11593407 PMID:11782540 PMID:11793474 PMID:11896595 PMID:11920788 PMID:11920959 PMID:12007217 PMID:12034820 PMID:12124823 PMID:12406399 PMID:12509279 PMID:12619118 PMID:12672316 PMID:12695689 PMID:12700230 PMID:12726864 PMID:12779080 PMID:12792784 PMID:12826609 PMID:12885464 PMID:12901974 PMID:12909720 PMID:12917626 PMID:14559903 PMID:14584079 PMID:14673037 PMID:15004724 PMID:15017592 PMID:15037740 PMID:15077194 PMID:15161705 PMID:15308588 PMID:15381368 PMID:15390294 PMID:15541116 PMID:15564800 PMID:15580553 PMID:15607980 PMID:15607981 PMID:15722483 PMID:15825182 PMID:15850016 PMID:15925506 PMID:15951970 PMID:15977174 PMID:15982667 PMID:16209708 PMID:16288208 PMID:16337994 PMID:16401470 PMID:16474844 PMID:16489069 PMID:16494995 PMID:16508005 PMID:16551709 PMID:16633321 PMID:16682957 PMID:16736287 PMID:16778209 PMID:16818505 PMID:16827139 PMID:16861262 PMID:17015838 PMID:17311302 PMID:17390010 PMID:17401428 PMID:17417627 PMID:17427234 PMID:17530187 PMID:17540308 PMID:17541742 PMID:17567834 PMID:17572079 PMID:17606709 PMID:17636407 PMID:17724467 PMID:17875924 PMID:18208484 PMID:18307025 PMID:18391940 PMID:18453682 PMID:18511570 PMID:18555592 PMID:18628487 PMID:18685109 PMID:19012332 PMID:19101993 PMID:19127115 PMID:19147582 PMID:19171880 PMID:19336573 PMID:19367569 PMID:19378321 PMID:19405127 PMID:19462533 PMID:19468865 PMID:19556618 PMID:19681600 PMID:19834951 PMID:19850740 PMID:19881536 PMID:19913028 PMID:19930417 PMID:20013323 PMID:20028212 PMID:20113312 PMID:20118236 PMID:20127978 PMID:20128691 PMID:20234365 PMID:20308654 PMID:20407015 PMID:20505364 PMID:20506564 PMID:20516128 PMID:20522432 PMID:20593220 PMID:20689556 PMID:20693561 PMID:20805372 PMID:20878954 PMID:20972454 PMID:21056685 PMID:21059199 PMID:21115975 PMID:21159183 PMID:21187651 PMID:21232794 PMID:21305319 PMID:21343334 PMID:21356188 PMID:21470402 PMID:21483000 PMID:21484931 PMID:21514416 PMID:21519010 PMID:21535297 PMID:21552135 PMID:21561095 PMID:21601526 PMID:21626334 PMID:21674059 PMID:21747090 PMID:21761402 PMID:22006311 PMID:22052707 PMID:22090360 PMID:22110706 PMID:22114072 PMID:22186996 PMID:22198284 PMID:22233476 PMID:22265402 PMID:22319594 PMID:22427690 PMID:22540896 PMID:22672556 PMID:22698404 PMID:22710932 PMID:22713868 PMID:22768918 PMID:22811390 PMID:22844452 PMID:22847613 PMID:22862161 PMID:22866089 PMID:22899716 PMID:22915647 PMID:22919068 PMID:22923379 PMID:22999923 PMID:23161690 PMID:23172776 PMID:23246812 PMID:23259501 PMID:23263379 PMID:23265383 PMID:23315175 PMID:23334668 PMID:23406775 PMID:23538418 PMID:23625637 PMID:23630318 PMID:23667202 PMID:23713777 PMID:23792586 PMID:23894400 PMID:23950206 PMID:23967324 PMID:24033266 PMID:24038938 PMID:24122735 PMID:24307375 PMID:24381225 PMID:24384472 PMID:24395441 PMID:24487413 PMID:24501221 PMID:24573247 PMID:24590827 PMID:24603336 PMID:24641375 PMID:24651012 PMID:24651015 PMID:24677579 PMID:24702488 PMID:24728327 PMID:24744791 PMID:24766216 PMID:24810334 PMID:24835218 PMID:24940547 PMID:25119136 PMID:25123297 PMID:25157968 PMID:25293557 PMID:25294809 PMID:25339994 PMID:25433984 PMID:25503501 PMID:25504633 PMID:25525159 PMID:25584008 PMID:25584637 PMID:25587027 PMID:25619955 PMID:25634208 PMID:25691460 PMID:25741868 PMID:25757876 PMID:25787918 PMID:25896519 PMID:25925845 PMID:25927356 PMID:25945745 PMID:25952993 PMID:25980754 PMID:26014290 PMID:26024390 PMID:26205489 PMID:26225655 PMID:26230955 PMID:26270727 PMID:26425688 PMID:26467025 PMID:26497680 PMID:26534844 PMID:26554828 PMID:26556299 PMID:26580448 PMID:26585234 PMID:26619011 PMID:26628864 PMID:26659639 PMID:26681312 PMID:26781615 PMID:26786923 PMID:26787237 PMID:26818906 PMID:26822237 PMID:26845104 PMID:26878390 PMID:26911350 PMID:26976419 PMID:27022024 PMID:27077130 PMID:27149858 PMID:27153395 PMID:27179933 PMID:27276561 PMID:27276934 PMID:27374712 PMID:27458004 PMID:27463065 PMID:27489289 PMID:27493922 PMID:27501770 PMID:27516001 PMID:27523101 PMID:27533082 PMID:27616075 PMID:27621308 PMID:27622479 PMID:27680515 PMID:27683180 PMID:27714481 PMID:27724982 PMID:27730344 PMID:27873457 PMID:27895058 PMID:27959731 PMID:28135145 PMID:28152038 PMID:28349240 PMID:28369373 PMID:28453743 PMID:28472496 PMID:28476805 PMID:28477316 PMID:28492532 PMID:28724667 PMID:28802053 PMID:28861920 PMID:28975465 PMID:29025599 PMID:29070607 PMID:29126202 PMID:29324801 PMID:29416011 PMID:29470806 PMID:29478780 PMID:29489754 PMID:29581140 PMID:29752822 PMID:29753700 PMID:29785153 PMID:29979965 PMID:30076369 PMID:30128536 PMID:30216591 PMID:30224644 PMID:30299350 PMID:30311369 PMID:30327374 PMID:30352134 PMID:30374176 PMID:30450585 PMID:30630526 PMID:30675318 PMID:30709381 PMID:30720243 PMID:30816478 PMID:30840781 PMID:31016814 PMID:31206626 PMID:31300551 PMID:31775759 PMID:32000721 PMID:32295079 PMID:32401780 |
|
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
|
G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
ISO |
|
RGD |
PMID:18059332 |
RGD:13782259 |
NCBI chr 1:256,382,861...256,386,729
Ensembl chr 1:256,382,791...256,386,729
|
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
ISO |
ClinVar Annotator: match by term: Breast adenocarcinoma, somatic |
ClinVar |
PMID:17611497 PMID:18256540 PMID:18392055 PMID:18504432 PMID:18611285 PMID:19418217 PMID:19487299 PMID:19853286 PMID:20233444 PMID:20453058 PMID:21464312 PMID:21512767 PMID:21793738 PMID:22538770 PMID:22610119 PMID:22722201 PMID:22722839 PMID:22980975 PMID:23237847 PMID:23348505 PMID:23700467 PMID:23728071 PMID:23934607 PMID:24190505 PMID:24657128 PMID:25157968 PMID:26619011 PMID:28492532 |
|
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
|
|
G |
Cat |
catalase |
|
ISO |
|
RGD |
PMID:25050522 |
RGD:9226881 |
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
|
|
G |
Ccne1 |
cyclin E1 |
|
ISO |
DNA:amplification |
RGD |
PMID:18089785 |
RGD:2289225 |
NCBI chr 1:94,485,830...94,495,112
Ensembl chr 1:94,485,832...94,494,980
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
IEP |
mRNA:increased expression:mammary epithelium (rat) |
RGD |
PMID:11097088 |
RGD:7829735 |
NCBI chr 6:2,308,179...2,316,739
Ensembl chr 6:2,307,808...2,316,722
|
|
G |
Fgfr3 |
fibroblast growth factor receptor 3 |
no_association |
ISO |
|
RGD |
PMID:11466624 |
RGD:2289868 |
NCBI chr14:82,272,322...82,287,739
Ensembl chr14:82,273,070...82,287,706
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
|
ISO |
ClinVar Annotator: match by term: Breast adenocarcinoma, somatic |
ClinVar |
PMID:2278970 PMID:2547513 PMID:3122217 PMID:3627975 PMID:12460918 PMID:15696205 PMID:16361624 PMID:16434492 PMID:16618717 PMID:17332249 PMID:17384584 PMID:18316791 PMID:18794081 PMID:19018267 PMID:19075190 PMID:19114683 PMID:19255327 PMID:19679400 PMID:19773371 PMID:20921462 PMID:20921465 PMID:20978259 PMID:21063026 PMID:21228335 PMID:21398618 PMID:21975775 PMID:22392911 PMID:22407852 PMID:22571758 PMID:22734028 PMID:23182985 PMID:23406027 PMID:24033266 PMID:24558511 PMID:24720724 PMID:25157968 PMID:25705018 PMID:25808193 PMID:26623049 |
|
NCBI chr 4:179,482,562...179,515,483
Ensembl chr 4:179,486,105...179,515,558
|
|
G |
Muc1 |
mucin 1, cell surface associated |
|
ISO |
mRNA,protein:increased expression:breast |
RGD |
PMID:7678777 |
RGD:2324855 |
NCBI chr 2:188,543,137...188,547,874
Ensembl chr 2:188,543,137...188,547,874
|
|
G |
Mxi1 |
MAX interactor 1, dimerization protein |
|
IAGP |
|
RGD |
PMID:10849326 |
RGD:1298988 |
NCBI chr 1:274,030,748...274,090,071
Ensembl chr 1:274,030,978...274,090,071
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
ISO |
ClinVar Annotator: match by term: Breast adenocarcinoma, somatic |
ClinVar |
PMID:15016963 PMID:15254419 PMID:15520168 PMID:15608678 PMID:15647370 PMID:15805248 PMID:16906227 PMID:16930767 PMID:17673550 PMID:18676830 PMID:18725974 PMID:19029981 PMID:19223544 PMID:19366826 PMID:19513541 PMID:19903786 PMID:20453058 PMID:20619739 PMID:21430269 PMID:21558396 PMID:22162582 PMID:22162589 PMID:22271473 PMID:22658544 PMID:22729222 PMID:22729223 PMID:22729224 PMID:23066039 PMID:23100325 PMID:23888070 PMID:24782230 PMID:25157968 PMID:25741868 PMID:26266975 PMID:26266985 PMID:26619011 PMID:26822237 PMID:27626068 PMID:29446767 PMID:31775759 |
|
NCBI chr 2:118,831,350...118,861,456
Ensembl chr 2:118,831,350...118,861,454
|
|
G |
Rb1cc1 |
RB1-inducible coiled-coil 1 |
|
ISO |
ClinVar Annotator: match by term: Breast adenocarcinoma |
ClinVar |
PMID:12068296 |
|
NCBI chr 5:13,033,918...13,097,369
Ensembl chr 5:13,033,918...13,097,341
|
|
G |
Slc22a18 |
solute carrier family 22, member 18 |
|
ISO |
ClinVar Annotator: match by term: Breast adenocarcinoma |
ClinVar |
PMID:9520460 |
|
NCBI chr 1:216,676,330...216,700,632
Ensembl chr 1:216,677,373...216,700,641
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
human protein in a rat model |
RGD |
PMID:12536235 |
RGD:14995452 |
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
ClinVar Annotator: match by term: Breast adenocarcinoma, somatic |
ClinVar |
PMID:1673792 PMID:1686725 PMID:7881428 PMID:8364550 PMID:10713666 PMID:11479205 PMID:11896595 PMID:11920959 PMID:12826609 PMID:16861262 PMID:17606709 PMID:20128691 PMID:20522432 PMID:21343334 PMID:23625637 PMID:25503501 PMID:25584008 PMID:26619011 PMID:28492532 PMID:29324801 PMID:29979965 PMID:30224644 |
|
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
|
G |
Abcc9 |
ATP binding cassette subfamily C member 9 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 4:176,806,098...176,928,540
Ensembl chr 4:176,805,431...176,922,424
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 4:148,398,004...148,446,308
Ensembl chr 4:148,398,892...148,446,303
|
|
G |
Amfr |
autocrine motility factor receptor |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr19:11,473,538...11,509,500
Ensembl chr19:11,473,541...11,508,102
|
|
G |
Bcar1 |
BCAR1 scaffold protein, Cas family member |
|
ISO |
|
RGD |
PMID:11605729 |
RGD:1579979 |
NCBI chr19:43,932,543...43,967,452
Ensembl chr19:43,932,554...43,955,783
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
PMID:9063749 PMID:10196379 PMID:11400546 PMID:14555511 PMID:15235020 PMID:16014699 PMID:17341484 PMID:17585057 PMID:19661094 PMID:20104584 PMID:21232165 PMID:21702907 PMID:21708019 PMID:21965345 PMID:21990134 PMID:22136207 PMID:22703879 PMID:23192404 PMID:23249957 PMID:23469205 PMID:24033266 PMID:24728327 PMID:25741868 PMID:28492532 |
|
NCBI chr10:89,394,821...89,455,093
Ensembl chr10:89,394,803...89,454,681
|
|
G |
Brca2 |
BRCA2, DNA repair associated |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
PMID:11062481 PMID:11927503 PMID:14555511 PMID:15235023 PMID:17767707 PMID:20135345 PMID:22703879 PMID:24033266 PMID:24323938 PMID:24728327 PMID:25741868 PMID:28492532 |
|
NCBI chr12:503,660...544,754
Ensembl chr12:504,007...544,748
|
|
G |
Bsg |
basigin (Ok blood group) |
|
ISO |
mRNA:increased expression:breast |
RGD |
PMID:9154157 |
RGD:2289059 |
NCBI chr 7:12,875,536...12,882,753
Ensembl chr 7:12,875,537...12,882,753
|
|
G |
Cacna1c |
calcium voltage-gated channel subunit alpha1 C |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 4:150,635,808...151,270,790
Ensembl chr 4:150,641,066...150,829,913
|
|
G |
Cacna1h |
calcium voltage-gated channel subunit alpha1 H |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
PMID:26467025 PMID:27148582 PMID:28492532 |
|
NCBI chr10:14,730,932...14,789,201
Ensembl chr10:14,730,941...14,788,617
|
|
G |
Ccdc180 |
coiled-coil domain containing 180 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 5:61,467,799...61,542,675
Ensembl chr 5:61,474,000...61,542,653
|
|
G |
Ccdc71l |
coiled-coil domain containing 71-like |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 6:51,659,498...51,666,145
Ensembl chr 6:51,662,224...51,662,874
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
disease_progression |
ISO |
mRNA, protein:splice variant, increased expression:breast |
RGD |
PMID:16425351 |
RGD:2289356 |
NCBI chr 3:92,695,083...92,783,820
Ensembl chr 3:92,696,313...92,783,658
|
|
G |
Cnnm1 |
cyclin and CBS domain divalent metal cation transport mediator 1 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 1:263,184,361...263,243,912
Ensembl chr 1:263,186,235...263,242,468
|
|
G |
Coro6 |
coronin 6 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr10:62,691,952...62,700,658
Ensembl chr10:62,691,953...62,699,723
|
|
G |
Cpxm2 |
carboxypeptidase X (M14 family), member 2 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 1:204,048,785...204,161,090
Ensembl chr 1:204,048,785...204,087,001
|
|
G |
Creb3 |
cAMP responsive element binding protein 3 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 5:59,063,532...59,068,196
Ensembl chr 5:59,063,531...59,068,188
|
|
G |
Ebag9 |
estrogen receptor binding site associated, antigen, 9 |
severity |
ISO |
protein:increased expression:breast |
RGD |
PMID:12054692 |
RGD:2298489 |
NCBI chr 7:83,564,563...83,582,516
Ensembl chr 7:83,564,563...83,582,508
|
|
G |
Fubp1 |
far upstream element binding protein 1 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 2:257,425,676...257,452,745
Ensembl chr 2:257,425,679...257,449,568
|
|
G |
Htra2 |
HtrA serine peptidase 2 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 4:113,883,671...113,886,833
Ensembl chr 4:113,883,670...113,886,994
|
|
G |
Kndc1 |
kinase non-catalytic C-lobe domain containing 1 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 1:212,229,751...212,279,254
Ensembl chr 1:212,230,259...212,277,694
|
|
G |
Lrat |
lecithin retinol acyltransferase |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 2:181,896,304...181,905,366
Ensembl chr 2:181,896,305...181,905,300
|
|
G |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 1:177,048,607...177,173,729
Ensembl chr 1:177,048,655...177,173,995
|
|
G |
Notch3 |
notch receptor 3 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 7:14,138,495...14,189,688
Ensembl chr 7:14,138,495...14,189,688
|
|
G |
Nts |
neurotensin |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 7:44,111,594...44,120,998
Ensembl chr 7:44,111,151...44,121,130
|
|
G |
Phf24 |
PHD finger protein 24 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 5:58,359,744...58,387,446
Ensembl chr 5:58,359,498...58,383,070
|
|
G |
Plk4 |
polo-like kinase 4 |
|
ISO |
protein:increased expression:breast |
RGD |
PMID:26439168 |
RGD:11075990 |
NCBI chr 2:127,686,911...127,705,518
Ensembl chr 2:127,686,925...127,705,518
|
|
G |
Pml |
PML nuclear body scaffold |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 8:63,002,515...63,034,310
Ensembl chr 8:63,004,870...63,034,226
|
|
G |
Rad54l |
RAD54 like |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
PMID:10362365 |
|
NCBI chr 5:134,948,511...134,978,125
Ensembl chr 5:134,948,512...134,978,125
|
|
G |
Rnf212 |
ring finger protein 212 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr14:1,959,148...1,998,077
Ensembl chr14:1,959,610...1,998,102
|
|
G |
Rp1 |
RP1, axonemal microtubule associated |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 5:15,005,028...15,060,508
Ensembl chr 5:15,043,955...15,060,508
|
|
G |
Rrp1 |
ribosomal RNA processing 1 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr20:10,982,016...10,993,260
Ensembl chr20:10,981,998...10,993,280
|
|
G |
Slitrk6 |
SLIT and NTRK-like family, member 6 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr15:95,507,632...95,514,259
Ensembl chr15:95,507,640...95,514,259
|
|
G |
Spen |
spen family transcriptional repressor |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 5:160,015,573...160,070,915
Ensembl chr 5:160,015,454...160,070,965
|
|
G |
Syt6 |
synaptotagmin 6 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 2:206,064,181...206,119,034
Ensembl chr 2:206,064,179...206,127,907
|
|
G |
Tnfrsf10b |
TNF receptor superfamily member 10b |
|
ISO |
mRNA:decreased expression:breast |
RGD |
PMID:17011986 |
RGD:2290492 |
NCBI chr15:51,433,853...51,464,215
|
|
G |
Tp73 |
tumor protein p73 |
|
ISO |
mRNA:decreased expression:breast |
RGD |
PMID:17011986 |
RGD:2290492 |
NCBI chr 5:171,355,876...171,415,354
Ensembl chr 5:171,355,876...171,415,354
|
|
G |
Tspan8 |
tetraspanin 8 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 7:58,814,805...58,847,564
Ensembl chr 7:58,814,805...58,847,563
|
|
G |
Tspear |
thrombospondin-type laminin G domain and EAR repeats |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr20:11,501,510...11,529,210
Ensembl chr20:11,501,925...11,528,332
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
severity |
ISO |
|
RGD |
PMID:17350670 |
RGD:2315853 |
NCBI chr X:128,409,425...128,455,786
Ensembl chr X:128,409,472...128,453,000
|
|
G |
Yeats2 |
YEATS domain containing 2 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr11:84,330,064...84,595,296
Ensembl chr11:84,330,064...84,583,542
|
|
G |
Zdbf2 |
zinc finger, DBF-type containing 2 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 9:70,052,088...70,090,847
Ensembl chr 9:70,059,683...70,089,778
|
|
G |
Zfp420 |
zinc finger protein 420 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 1:88,531,975...88,564,480
Ensembl chr 1:88,542,035...88,544,156
|
|
G |
Zfp473 |
zinc finger protein 473 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 1:100,736,319...100,755,498
Ensembl chr 1:100,736,243...100,746,021
|
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8389152 |
|
NCBI chr17:35,907,102...35,958,136
Ensembl chr17:35,907,108...35,958,077
|
|
G |
Agtr2 |
angiotensin II receptor, type 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8389152 |
|
NCBI chr X:119,389,480...119,393,845
Ensembl chr X:119,390,013...119,393,842
|
|
G |
Cdh1 |
cadherin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8557030 PMID:17660459 |
|
NCBI chr19:38,768,467...38,838,395
Ensembl chr19:38,768,467...38,838,395
|
|
G |
Myh9 |
myosin, heavy chain 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28650484 |
|
NCBI chr 7:118,740,005...118,792,507
Ensembl chr 7:118,741,110...118,792,625
|
|
G |
Ppp1r12b |
protein phosphatase 1, regulatory subunit 12B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28650484 |
|
NCBI chr13:51,583,603...51,784,641
Ensembl chr13:51,584,299...51,784,639
|
|
G |
Stat5a |
signal transducer and activator of transcription 5A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15609129 |
|
NCBI chr10:88,764,732...88,789,060
Ensembl chr10:88,764,732...88,789,057
|
|
G |
Tp53bp2 |
tumor protein p53 binding protein, 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28650484 |
|
NCBI chr13:100,817,206...100,873,837
Ensembl chr13:100,817,359...100,873,890
|
|
|
G |
Ccnd1 |
cyclin D1 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:14674039 |
RGD:13434930 |
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
disease_progression |
ISO |
|
RGD |
PMID:19484794 |
RGD:4140940 |
NCBI chr 8:21,922,515...21,968,495
Ensembl chr 8:21,922,515...21,968,495
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO IMP |
DNA:snp:cds:p.T790M (human) DNA:mutations:exons: protein:increased expression:tumor (human) |
RGD |
PMID:15737014, PMID:26059825, PMID:21419590 |
RGD:5131465, RGD:11075076, RGD:5131630 |
NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
|
|
G |
Egr1 |
early growth response 1 |
|
ISO |
mRNA:decreased expression:tumor (human) |
RGD |
PMID:11948124 |
RGD:5131942 |
NCBI chr18:27,657,903...27,660,101
Ensembl chr18:27,657,628...27,661,429
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
ISO |
DNA:hypermethylation:promoter (human) |
RGD |
PMID:19484794 |
RGD:4140940 |
NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
|
IMP |
DNA:mutations:cds: |
RGD |
PMID:26059825 |
RGD:11075076 |
NCBI chr 4:179,482,562...179,515,483
Ensembl chr 4:179,486,105...179,515,558
|
|
G |
Mir130a |
microRNA 130a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25926378 |
|
NCBI chr 3:72,141,037...72,141,124
Ensembl chr 3:72,141,037...72,141,124
|
|
G |
Mir144 |
microRNA 144 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25926378 |
|
NCBI chr10:65,291,365...65,291,447
Ensembl chr10:65,291,365...65,291,447
|
|
G |
Mir19a |
microRNA 19a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25926378 |
|
NCBI chr15:100,180,162...100,180,243
Ensembl chr15:100,180,162...100,180,243
|
|
G |
Mir345 |
microRNA 345 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25926378 |
|
NCBI chr 6:132,748,968...132,749,063
Ensembl chr 6:132,748,968...132,749,063
|
|
G |
Mir497 |
microRNA 497 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25926378 |
|
NCBI chr10:56,844,977...56,845,045
Ensembl chr10:56,844,977...56,845,045
|
|
G |
Tp53 |
tumor protein p53 |
|
IMP |
DNA:mutations:exons: |
RGD |
PMID:26059825 |
RGD:11075076 |
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
|
G |
Alb |
albumin |
|
ISO |
protein:decreased expression:serum: |
RGD |
PMID:975003 |
RGD:11036087 |
NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
|
|
G |
Eno2 |
enolase 2 |
|
ISO |
|
RGD |
PMID:17345775 |
RGD:2293739 |
NCBI chr 4:157,285,192...157,294,090
Ensembl chr 4:157,285,179...157,294,047
|
|
G |
Men1 |
menin 1 |
|
ISO |
DNA:loss of heterozygosity:lung:PYGM,D11S449,D11S906(human) |
RGD |
PMID:16465412 |
RGD:2317351 |
NCBI chr 1:221,704,394...221,710,343
Ensembl chr 1:221,704,493...221,710,331
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
ISO |
DNA:hypermethylation:promoter (human) |
RGD |
PMID:12584572 |
RGD:2317635 |
NCBI chr 1:209,237,255...209,464,189
Ensembl chr 1:209,237,233...209,464,190
|
|
G |
Mir10a |
microRNA 10a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr10:84,165,950...84,166,059
Ensembl chr10:84,165,950...84,166,059
|
|
G |
Mir127 |
microRNA 127 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 6:133,713,430...133,713,526
Ensembl chr 6:133,713,430...133,713,526
|
|
G |
Mir136 |
microRNA 136 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 6:133,716,761...133,716,842
Ensembl chr 6:133,716,761...133,716,842
|
|
G |
Mir146a |
microRNA 146a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr10:28,962,476...28,962,570
Ensembl chr10:28,962,476...28,962,570
|
|
G |
Mir154 |
microRNA 154 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 6:133,888,586...133,888,669
Ensembl chr 6:133,888,586...133,888,669
|
|
G |
Mir155 |
microRNA 155 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr11:24,176,603...24,176,667
Ensembl chr11:24,176,603...24,176,667
|
|
G |
Mir193a |
microRNA 193a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr10:67,065,885...67,065,996
Ensembl chr10:67,065,885...67,065,996
|
|
G |
Mir222 |
microRNA 222 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr X:3,683,919...3,684,021
Ensembl chr X:3,683,919...3,684,021
|
|
G |
Mir224 |
microRNA 224 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr X:152,223,754...152,223,835
Ensembl chr X:152,223,754...152,223,835
|
|
G |
Mir30a |
microRNA 30a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 9:29,542,635...29,542,705
Ensembl chr 9:29,542,635...29,542,705
|
|
G |
Mir34b |
microRNA 34b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 8:55,492,542...55,492,625
Ensembl chr 8:55,492,542...55,492,625
|
|
G |
Mir34c |
microRNA 34c |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 8:55,492,024...55,492,100
Ensembl chr 8:55,492,024...55,492,100
|
|
G |
Mir370 |
microRNA 370 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 6:133,739,916...133,739,994
Ensembl chr 6:133,739,916...133,739,994
|
|
G |
Mir409 |
microRNA 409 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 6:133,893,419...133,893,495
|
|
G |
Mir410 |
microRNA 410 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 6:133,893,997...133,894,072
Ensembl chr 6:133,893,993...133,894,073
|
|
G |
Mir487b |
microRNA 487b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 6:133,877,124...133,877,205
Ensembl chr 6:133,877,124...133,877,205
|
|
G |
Mir494 |
microRNA 494 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 6:133,864,370...133,864,452
Ensembl chr 6:133,864,369...133,864,453
|
|
G |
Reg1a |
regenerating family member 1 alpha |
|
ISO |
associated with Hypergastrinemia;DNA:missense mutations:cds:multiple (human) |
RGD |
PMID:10348814 |
RGD:9850135 |
NCBI chr 4:109,497,962...109,500,626
Ensembl chr 4:109,497,962...109,501,082
|
|
|
G |
Spink1 |
serine peptidase inhibitor, Kazal type 1 |
|
ISO |
|
RGD |
PMID:2258083 |
RGD:2300391 |
NCBI chr18:38,221,919...38,242,092
Ensembl chr18:38,221,681...38,242,119
|
|
G |
Tff1 |
trefoil factor 1 |
|
ISO |
mRNA, protein:increased expression:uterine cervix |
RGD |
PMID:10727981 |
RGD:2298570 |
NCBI chr20:9,892,124...9,895,984
Ensembl chr20:9,892,124...9,895,984
|
|
G |
Tfrc |
transferrin receptor |
|
ISO |
protein:increased expression:uterine cervix |
RGD |
PMID:9739406 |
RGD:2292022 |
NCBI chr11:71,397,423...71,419,263
Ensembl chr11:71,397,383...71,419,223
|
|
G |
Tp53 |
tumor protein p53 |
disease_progression |
ISO |
|
RGD |
PMID:17354237 |
RGD:2298527 |
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
|
G |
Stk11 |
serine/threonine kinase 11 |
disease_progression |
ISO |
DNA:mutations |
RGD |
PMID:12533684 |
RGD:2291947 |
NCBI chr 7:12,440,751...12,457,513
Ensembl chr 7:12,440,751...12,457,513
|
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
susceptibility |
ISO |
DNA:polymorphism:exon:c.3972C>T (human) |
RGD |
PMID:19451719 |
RGD:2317508 |
NCBI chr 1:263,554,426...263,612,556
Ensembl chr 1:263,554,453...263,613,252
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
|
ISO |
protein:decreased expression:liver |
RGD |
PMID:16292515 |
RGD:2325640 |
NCBI chr18:57,513,792...57,515,834
Ensembl chr18:57,513,793...57,515,834
|
|
G |
Alb |
albumin |
disease_progression |
ISO |
|
RGD |
PMID:10776430, PMID:20431764, PMID:17545000 |
RGD:2325682, RGD:2325679, RGD:2325680 |
NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
ISO |
protein:increased expression:bile duct |
RGD |
PMID:18507031 |
RGD:2317521 |
NCBI chr 4:148,398,004...148,446,308
Ensembl chr 4:148,398,892...148,446,303
|
|
G |
Anxa2 |
annexin A2 |
disease_progression |
ISO |
|
RGD |
PMID:20493868 |
RGD:2325728 |
NCBI chr 8:75,687,134...75,723,589
Ensembl chr 8:75,687,100...75,723,594
|
|
G |
Anxa8 |
annexin A8 |
|
ISO |
|
RGD |
PMID:19376120 |
RGD:2325733 |
NCBI chr16:10,417,174...10,432,388
Ensembl chr16:10,417,185...10,432,393
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO |
DNA:hypermethylation:promoter DNA:loss of heterozygosity |
RGD |
PMID:15467712, PMID:10212000 |
RGD:2317198, RGD:2317205 |
NCBI chr18:27,011,710...27,106,323
Ensembl chr18:27,047,382...27,105,531
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
ISO |
protein:decreased expression:serum |
RGD |
PMID:19486127 |
RGD:2325756 |
NCBI chr 8:50,525,091...50,526,875
Ensembl chr 8:50,525,091...50,526,875
|
|
G |
Arid1a |
AT-rich interaction domain 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 |
|
NCBI chr 5:151,904,687...151,977,973
Ensembl chr 5:151,904,684...151,977,636
|
|
G |
Asph |
aspartate-beta-hydroxylase |
|
ISO |
|
RGD |
PMID:21898484 |
RGD:6902945 |
NCBI chr 5:22,577,680...22,799,333
Ensembl chr 5:22,577,675...22,799,349
|
|
G |
Bap1 |
Brca1 associated protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 PMID:25231345 |
|
NCBI chr16:7,336,685...7,345,511
Ensembl chr16:7,336,685...7,345,511
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
|
IAGP |
DNA:missense mutation:cds:p.V600E (human) |
RGD |
PMID:12692057 |
RGD:11073239 |
NCBI chr 4:67,389,331...67,520,549
Ensembl chr 4:67,396,192...67,520,356
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
onset |
ISO |
protein:decreased expression:liver |
RGD |
PMID:15619210 |
RGD:2317417 |
NCBI chr 5:107,823,323...107,832,405
Ensembl chr 5:107,823,330...107,841,175
|
|
G |
Cycs |
cytochrome c, somatic |
|
ISO |
|
RGD |
PMID:19788692 |
RGD:2317615 |
NCBI chr 4:80,331,226...80,333,326
Ensembl chr 4:80,331,227...80,333,326
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17341899 |
|
NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
|
|
G |
Epo |
erythropoietin |
|
IEP |
mRNA, protein:increased expression:liver |
RGD |
PMID:23052842 |
RGD:10400912 |
NCBI chr12:22,274,828...22,278,268
Ensembl chr12:22,274,828...22,278,266
|
|
G |
Epor |
erythropoietin receptor |
|
IEP |
mRNA, protein:increased expression:liver |
RGD |
PMID:23052842 |
RGD:10400912 |
NCBI chr 8:22,969,737...22,974,468
Ensembl chr 8:22,969,745...22,974,321
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16818635 |
|
NCBI chr10:86,367,596...86,391,728
Ensembl chr10:86,367,596...86,391,728
|
|
G |
Faslg |
Fas ligand |
|
ISO |
|
RGD |
PMID:11029528 |
RGD:2317746 |
NCBI chr13:79,696,811...79,717,581
Ensembl chr13:79,698,445...79,705,705
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
|
ISO |
protein:increased expression:bile |
RGD |
PMID:11478488 |
RGD:2317765 |
NCBI chr 2:124,081,072...124,134,133
Ensembl chr 2:124,081,072...124,134,681
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26258846 |
|
NCBI chr 1:200,590,951...200,696,946
Ensembl chr 1:200,590,953...200,696,928
|
|
G |
Fscn1 |
fascin actin-bundling protein 1 |
disease_progression |
ISO |
protein:increased expression:bile ducts |
RGD |
PMID:19721413 |
RGD:2317780 |
NCBI chr12:13,655,459...13,668,595
Ensembl chr12:13,656,554...13,668,515
|
|
G |
Gnas |
GNAS complex locus |
disease_progression |
ISO |
DNA:polymorphism:393T>C (human) CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561520, PMID:17356712 |
RGD:1601377 |
NCBI chr 3:172,374,957...172,434,988
Ensembl chr 3:172,374,957...172,428,483 Ensembl chr 3:172,374,957...172,428,483
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
|
ISO |
|
RGD |
PMID:24049014 |
RGD:14700980 |
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
treatment |
ISO |
DNA:hypermethylation:promoter human cell line in a mouse model |
RGD |
PMID:15467712, PMID:12805482 |
RGD:2317198, RGD:14401711 |
NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
|
|
G |
Hdac6 |
histone deacetylase 6 |
|
ISO |
protein:increased expression:liver: |
RGD |
PMID:23370327 |
RGD:9681560 |
NCBI chr X:15,295,372...15,316,673
Ensembl chr X:15,295,473...15,316,671
|
|
G |
Hgf |
hepatocyte growth factor |
|
IEP ISO |
mRNA, protein:increased expression: : protein:increased expression:serum |
RGD |
PMID:10827151, PMID:16974053 |
RGD:2317925, RGD:2317909 |
NCBI chr 4:15,435,460...15,505,377
Ensembl chr 4:15,433,295...15,505,362
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 |
|
NCBI chr 9:71,882,108...71,911,645
Ensembl chr 9:71,882,105...71,900,044
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 |
|
NCBI chr 1:141,874,354...141,893,674
Ensembl chr 1:141,866,283...141,893,705
|
|
G |
Il4r |
interleukin 4 receptor |
|
ISO |
mRNA:increased expression:bile duct |
RGD |
PMID:18798553 |
RGD:2317263 |
NCBI chr 1:196,942,343...196,967,221
Ensembl chr 1:196,942,364...196,967,220
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
protein:increased expression:serum CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17621267, PMID:15011822, PMID:28925763 |
RGD:2317167, RGD:14975292 |
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
|
|
G |
Kmt2c |
lysine methyltransferase 2C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561520 |
|
NCBI chr 4:82,506...109,986 NCBI chr 4:6,083,650...6,294,413
Ensembl chr 4:6,083,736...6,292,516
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8968066 PMID:22561520 |
|
NCBI chr 4:179,482,562...179,515,483
Ensembl chr 4:179,486,105...179,515,558
|
|
G |
Krt7 |
keratin 7 |
|
ISO |
|
RGD |
PMID:18393293 |
RGD:2317308 |
NCBI chr 7:143,059,731...143,075,907
Ensembl chr 7:143,059,764...143,075,907
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
disease_progression |
ISO |
protein:increased expression:intrahepatic bile duct (human) |
RGD |
PMID:15619210 |
RGD:2317417 |
NCBI chr 7:60,719,060...60,743,618
Ensembl chr 7:60,719,066...60,743,328
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
disease_progression |
IEP ISO |
protein:increased expression:liver, biliary epithelium (rat) protein:increased phosphorylation:liver, carcinoma (human) |
RGD |
PMID:14656942, PMID:16818635 |
RGD:2317601, RGD:2317578 |
NCBI chr 4:44,747,467...44,854,628
Ensembl chr 4:44,774,741...44,852,665
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
ISO |
DNA:hypermethylation:promoter (human) |
RGD |
PMID:17550320 |
RGD:2317632 |
NCBI chr 1:209,237,255...209,464,189
Ensembl chr 1:209,237,233...209,464,190
|
|
G |
Mir155 |
microRNA 155 |
|
ISO |
miRNA:increased expression:serum |
RGD |
PMID:30653586 |
RGD:21081530 |
NCBI chr11:24,176,603...24,176,667
Ensembl chr11:24,176,603...24,176,667
|
|
G |
Mir192 |
microRNA 192 |
|
ISO |
RNA:increased expression:urine |
RGD |
PMID:26456596 |
RGD:41404678 |
NCBI chr 1:221,634,971...221,635,080
Ensembl chr 1:221,634,971...221,635,080
|
|
G |
Mir21 |
microRNA 21 |
|
ISO |
RNA:increased expression:urine |
RGD |
PMID:26456596 |
RGD:41404678 |
NCBI chr10:73,902,210...73,902,301
Ensembl chr10:73,902,210...73,902,301
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
disease_progression |
ISO |
|
RGD |
PMID:12903495 |
RGD:2317705 |
NCBI chr 1:207,993,895...208,020,454
Ensembl chr 1:207,993,895...208,020,454
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
disease_progression |
IEP ISO |
protein:increased expression:bile duct |
RGD |
PMID:15213623, PMID:19629755 |
RGD:2324667, RGD:2325769 |
NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO IEP |
mRNA:increased expression:bile duct protein:increased expression:bile duct |
RGD |
PMID:16463672, PMID:15213623, PMID:15213623 |
RGD:2325856, RGD:2324667, RGD:2324667 |
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
|
|
G |
Msln |
mesothelin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14576474 |
|
NCBI chr10:15,119,700...15,129,129
Ensembl chr10:15,119,663...15,125,408
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
susceptibility |
ISO |
DNA:polymorphism (human) |
RGD |
PMID:17201138 |
RGD:2317119 |
NCBI chr 5:164,844,642...164,864,360
Ensembl chr 5:164,845,925...164,860,910
|
|
G |
Muc1 |
mucin 1, cell surface associated |
disease_progression |
ISO IEP |
protein:increased secretion:bile protein:increased expression:serum protein:increased expression:bile duct: mRNA:increased expression:bile duct |
RGD |
PMID:19055478, PMID:19260467, PMID:15213623, PMID:18081149, PMID:19639217 |
RGD:2324622, RGD:2324664, RGD:2324667, RGD:2324638, RGD:2317986 |
NCBI chr 2:188,543,137...188,547,874
Ensembl chr 2:188,543,137...188,547,874
|
|
G |
Muc16 |
mucin 16, cell surface associated |
|
ISO |
associated with Opisthorchiasis;protein:increased expression:serum |
RGD |
PMID:1653472 |
RGD:2325142 |
NCBI chr 8:18,438,838...18,639,777
|
|
G |
Muc2 |
mucin 2, oligomeric mucus/gel-forming |
|
ISO |
mRNA:decreased expression:bile duct |
RGD |
PMID:11680592 |
RGD:2324948 |
NCBI chr 1:214,663,929...214,693,197
|
|
G |
Muc3 |
mucin 3, intestinal |
|
ISO |
mRNA:decreased expression:bile duct |
RGD |
PMID:11680592 |
RGD:2324948 |
NCBI chr12:22,535,663...22,584,775
|
|
G |
Muc4 |
mucin 4, cell surface associated |
disease_progression |
ISO IEP |
protein:increased expression:bile duct |
RGD |
PMID:14752841, PMID:19082442 |
RGD:2324944, RGD:2303602 |
NCBI chr11:71,242,973...71,285,217
Ensembl chr11:71,243,334...71,284,939
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
disease_progression |
ISO |
protein:increased expression:serum mRNA:increased expression:bile duct |
RGD |
PMID:14508831, PMID:11680592 |
RGD:2324990, RGD:2324948 |
NCBI chr 1:214,725,482...214,756,653
|
|
G |
Muc5b |
mucin 5B, oligomeric mucus/gel-forming |
|
ISO |
mRNA:decreased expression:bile duct |
RGD |
PMID:11680592 |
RGD:2324948 |
NCBI chr 1:214,778,459...214,811,237
Ensembl chr 1:214,778,496...214,810,720
|
|
G |
Muc6 |
mucin 6, oligomeric mucus/gel-forming |
|
ISO |
protein:increased expression: : |
RGD |
PMID:10209489 |
RGD:2325167 |
NCBI chr 1:214,608,453...214,630,524
Ensembl chr 1:214,608,704...214,629,938
|
|
G |
Nat2 |
N-acetyltransferase 2 |
|
ISO |
DNA:polymorphisms (human) |
RGD |
PMID:15901993 |
RGD:2317172 |
NCBI chr16:23,960,709...23,991,570
Ensembl chr16:23,961,067...23,991,570
|
|
G |
Ncam1 |
neural cell adhesion molecule 1 |
|
ISO |
associated with hepatitis |
RGD |
PMID:12031086 |
RGD:2326079 |
NCBI chr 8:53,836,797...54,134,881
Ensembl chr 8:53,839,098...53,901,358
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
protein:increased expression:bile duct CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16818635, PMID:16094703 |
RGD:2325280 |
NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
|
|
G |
Notch1 |
notch receptor 1 |
|
ISO |
protein:increased expression:cholangiocyte |
RGD |
PMID:15887117 |
RGD:2325330 |
NCBI chr 3:3,905,562...3,951,015
Ensembl chr 3:3,905,453...3,951,025
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
disease_progression |
IEP |
mRNA:decreased expression:liver (rat) |
RGD |
PMID:24255171 |
RGD:15090822 |
NCBI chr 7:30,003,429...30,162,095
Ensembl chr 7:30,003,429...30,162,056
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
disease_progression |
ISO |
DNA:loss of heterozygosity (human) |
RGD |
PMID:11866974, PMID:11260864 |
RGD:2317134, RGD:2317136 |
NCBI chr 4:145,282,828...145,289,367
Ensembl chr 4:145,282,797...145,289,326
|
|
G |
Osbp2 |
oxysterol binding protein 2 |
|
ISO |
mRNA:increased expression:blood |
RGD |
PMID:21763455 |
RGD:41404644 |
NCBI chr14:83,943,976...84,107,031
Ensembl chr14:83,943,977...84,106,997
|
|
G |
Osbpl7 |
oxysterol binding protein-like 7 |
|
ISO |
mRNA:increased expression:blood |
RGD |
PMID:21763455 |
RGD:41404644 |
NCBI chr10:84,986,330...85,003,947
Ensembl chr10:84,986,328...85,004,562
|
|
G |
Pawr |
pro-apoptotic WT1 regulator |
|
ISO |
mRNA,protein:decreased expression:cholangiocyte: |
RGD |
PMID:20724592 |
RGD:9835357 |
NCBI chr 7:51,273,764...51,353,700
Ensembl chr 7:51,273,771...51,353,068
|
|
G |
Pbrm1 |
polybromo 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 |
|
NCBI chr16:7,103,714...7,202,899
Ensembl chr16:7,103,998...7,200,362
|
|
G |
Peg3 |
paternally expressed 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561520 |
|
NCBI chr 1:70,210,810...70,237,450
Ensembl chr 1:70,222,964...70,237,443
|
|
G |
Prkaca |
protein kinase cAMP-activated catalytic subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26258846 |
|
NCBI chr19:25,095,089...25,118,869
Ensembl chr19:25,095,089...25,118,860
|
|
G |
Prkacb |
protein kinase cAMP-activated catalytic subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26258846 |
|
NCBI chr 2:252,602,197...252,691,886
Ensembl chr 2:252,605,307...252,691,886
|
|
G |
Prss2 |
protease, serine, 2 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:8621252 |
RGD:2324908 |
NCBI chr 4:70,689,737...70,694,816
Ensembl chr 4:70,689,737...70,694,761
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27022031, PMID:23376645 |
RGD:12802341 |
NCBI chr 1:251,421,814...251,487,634
Ensembl chr 1:251,421,596...251,487,832
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
protein:increased expression:bile duct CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16818635, PMID:19621664 |
RGD:2317180 |
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
|
|
G |
Reg1a |
regenerating family member 1 alpha |
susceptibility |
ISO |
mRNA, protein:increased expression:liver (human) |
RGD |
PMID:11343228 |
RGD:10044031 |
NCBI chr 4:109,497,962...109,500,626
Ensembl chr 4:109,497,962...109,501,082
|
|
G |
Rnf43 |
ring finger protein 43 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561520 |
|
NCBI chr10:74,956,411...75,028,951
Ensembl chr10:74,959,285...75,028,951
|
|
G |
Robo2 |
roundabout guidance receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561520 |
|
NCBI chr11:11,062,866...12,618,793
Ensembl chr11:11,062,790...11,585,765
|
|
G |
Runx3 |
RUNX family transcription factor 3 |
|
ISO |
protein:decreased expression:bile duct |
RGD |
PMID:19827872 |
RGD:2324955 |
NCBI chr 5:153,507,093...153,531,137
Ensembl chr 5:153,507,093...153,531,137
|
|
G |
Slc5a5 |
solute carrier family 5 member 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17408651 |
|
NCBI chr16:20,297,414...20,307,401
Ensembl chr16:20,297,414...20,307,400
|
|
G |
Smad4 |
SMAD family member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561520 |
|
NCBI chr18:69,626,682...69,657,373
Ensembl chr18:69,627,757...69,671,199
|
|
G |
Sox17 |
SRY-box transcription factor 17 |
severity |
IEP |
|
RGD |
PMID:20816680 |
RGD:4889598 |
NCBI chr 5:14,890,318...14,895,907
Ensembl chr 5:14,890,408...14,895,907
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
disease_progression |
ISO IEP |
protein:increased expression:pancreas |
RGD |
PMID:16083599, PMID:12632524 |
RGD:2325020, RGD:1299231 |
NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
|
|
G |
Tgfbr2 |
transforming growth factor, beta receptor 2 |
|
IEP |
mRNA:increased expression:bile duct |
RGD |
PMID:12632524 |
RGD:1299231 |
NCBI chr 8:124,310,288...124,399,345
Ensembl chr 8:124,312,754...124,399,494
|
|
G |
Thbs1 |
thrombospondin 1 |
disease_progression |
ISO |
DNA:hypermethylation (human) |
RGD |
PMID:11927969, PMID:12213730, PMID:16465407 |
RGD:2325027, RGD:2325026, RGD:2325024 |
NCBI chr 3:109,862,120...109,873,466
Ensembl chr 3:109,862,117...109,873,466
|
|
G |
Tnc |
tenascin C |
severity |
IEP |
|
RGD |
PMID:20816680 |
RGD:4889598 |
NCBI chr 5:79,789,686...79,874,555
Ensembl chr 5:79,789,671...79,874,671
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16818635 PMID:22561520 |
|
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
|
ISO |
|
RGD |
PMID:9230212 |
RGD:2325161 |
NCBI chr 9:95,161,157...95,302,822
Ensembl chr 9:95,161,157...95,302,822
|
|
|
G |
Fgf8 |
fibroblast growth factor 8 |
|
ISO |
testicular germ cell neoplasms |
RGD |
PMID:11764380 |
RGD:2289339 |
NCBI chr 1:265,492,949...265,498,965
Ensembl chr 1:265,493,124...265,498,831
|
|
G |
Igf2 |
insulin-like growth factor 2 |
disease_progression |
ISO |
|
RGD |
PMID:17556377 |
RGD:2290454 |
NCBI chr 1:215,828,102...215,839,081
Ensembl chr 1:215,828,102...215,846,911
|
|
G |
Insr |
insulin receptor |
disease_progression |
ISO |
|
RGD |
PMID:17556377 |
RGD:2290454 |
NCBI chr12:1,682,527...1,816,414
Ensembl chr12:1,680,957...1,816,414
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
|
ISO |
mRNA:increased expression:mononuclear cytotrophoblast cell |
RGD |
PMID:8504434 |
RGD:2292200 |
NCBI chr 7:121,215,458...121,233,092
Ensembl chr 7:121,214,628...121,232,741
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
|
ISO |
mRNA:increased expression:mononuclear cytotrophoblast cell |
RGD |
PMID:8504434 |
RGD:2292200 |
NCBI chr18:56,364,586...56,406,381
Ensembl chr18:56,364,620...56,406,381
|
|
G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
ISO |
DNA, protein:hypermethylation, decreased expression:promoter, placenta |
RGD |
PMID:15507671 |
RGD:2290418 |
NCBI chr 7:23,543,125...23,594,170
Ensembl chr 7:23,544,215...23,594,133
|
|
|
G |
Hnf1a |
HNF1 homeobox A |
|
ISO |
ClinVar Annotator: match by term: Chromophobe renal cell carcinoma |
ClinVar |
PMID:9392505 PMID:9754819 PMID:10966642 PMID:11393552 PMID:15649945 PMID:17573900 PMID:19169489 PMID:19929997 PMID:21696527 PMID:22348187 PMID:22432108 PMID:25741868 PMID:26467025 PMID:27148439 PMID:28395978 PMID:28492532 PMID:31576961 PMID:31638168 |
|
NCBI chr12:47,407,811...47,433,342
Ensembl chr12:47,407,811...47,433,342
|
|
G |
Hnf1b |
HNF1 homeobox B |
|
ISO |
ClinVar Annotator: match by term: Chromophobe renal cell carcinoma |
ClinVar |
PMID:15649945 PMID:16371430 PMID:25536396 PMID:25700310 PMID:25741868 |
|
NCBI chr10:71,159,863...71,218,902
Ensembl chr10:71,159,869...71,218,902
|
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9754764 |
|
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Cbx7 |
chromobox 7 |
disease_progression |
ISO |
|
RGD |
PMID:24375438 |
RGD:9587359 |
NCBI chr 7:121,136,067...121,153,503
Ensembl chr 7:121,136,058...121,153,383
|
|
G |
Daxx |
death-domain associated protein |
|
ISO |
protein:increased expression:ovary: |
RGD |
PMID:23539629 |
RGD:9587820 |
NCBI chr20:5,480,103...5,485,962
Ensembl chr20:5,480,103...5,485,926
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9754764 |
|
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
|
ISO |
mRNA:increased expression:renal cortex (human) |
RGD |
PMID:21947243 |
RGD:7244181 |
NCBI chr20:4,363,152...4,366,079
Ensembl chr20:4,363,152...4,366,079
|
|
G |
Atp5mc2 |
ATP synthase membrane subunit c locus 2 |
|
ISO |
|
RGD |
PMID:28672194 |
RGD:14696810 |
NCBI chr 7:144,264,207...144,272,578
Ensembl chr 7:144,264,199...144,272,578
|
|
G |
Atp5pb |
ATP synthase peripheral stalk-membrane subunit b |
|
ISO |
|
RGD |
PMID:28672194 |
RGD:14696810 |
NCBI chr 2:208,566,385...208,577,147
Ensembl chr 2:208,566,385...208,577,146
|
|
G |
Atp5po |
ATP synthase peripheral stalk subunit OSCP |
|
ISO |
|
RGD |
PMID:28672194 |
RGD:14696810 |
NCBI chr11:32,081,606...32,087,918
Ensembl chr11:32,081,574...32,088,002
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
|
ISO |
mRNA, protein:increased expression:kidney |
RGD |
PMID:28551630 |
RGD:15036804 |
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27292127 |
|
NCBI chr 8:21,922,515...21,968,495
Ensembl chr 8:21,922,515...21,968,495
|
|
G |
Dnmt3a |
DNA methyltransferase 3 alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27292127 |
|
NCBI chr 6:28,205,375...28,346,052
Ensembl chr 6:28,235,695...28,340,577
|
|
G |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
disease_progression |
ISO |
|
RGD |
PMID:23788753 |
RGD:13506731 |
NCBI chr 6:75,050,329...75,075,795
Ensembl chr 6:75,050,329...75,075,795
|
|
G |
Eng |
endoglin |
severity |
ISO |
protein:increased expression:tumor, vasculature (human) protein:decreased expression:kidney, tumor (human) |
RGD |
PMID:22204709, PMID:16536758 |
RGD:7248775, RGD:7248780 |
NCBI chr 3:11,679,530...11,717,486
Ensembl chr 3:11,679,530...11,717,485
|
|
G |
Ep300 |
E1A binding protein p300 |
severity |
ISO |
mRNA:altered expression:kidney, tumor (human) mRNA, protein:increased expression:kidney |
RGD |
PMID:23029358, PMID:28551630 |
RGD:7296925, RGD:15036804 |
NCBI chr 7:122,818,194...122,889,055
Ensembl chr 7:122,818,975...122,861,296
|
|
G |
F2 |
coagulation factor II |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:22065054 |
RGD:6893520 |
NCBI chr 3:80,529,468...80,542,993
Ensembl chr 3:80,529,428...80,543,031
|
|
G |
Flt4 |
Fms related receptor tyrosine kinase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25239121 |
|
NCBI chr10:35,078,782...35,120,296
Ensembl chr10:35,078,726...35,121,599
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
ISO |
|
RGD |
PMID:10383153 |
RGD:6906878 |
NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
|
|
G |
Hnf1a |
HNF1 homeobox A |
|
ISO |
ClinVar Annotator: match by term: Clear cell carcinoma of kidney |
ClinVar |
PMID:8866553 PMID:8945470 PMID:9032114 PMID:9045858 PMID:9075818 PMID:9166684 PMID:9313763 PMID:9392505 PMID:9439666 PMID:9754819 PMID:10333057 PMID:10447526 PMID:10754480 PMID:10966642 PMID:11058894 PMID:11315851 PMID:11393552 PMID:12050210 PMID:12355088 PMID:12530534 PMID:12574234 PMID:12618559 PMID:15649945 PMID:15928245 PMID:17054605 PMID:17407387 PMID:17440016 PMID:17573900 PMID:17937063 PMID:17989309 PMID:18414213 PMID:18672310 PMID:19169489 PMID:19929997 PMID:21051477 PMID:21628466 PMID:21696527 PMID:22348187 PMID:22432108 PMID:23551881 PMID:23607861 PMID:25174781 PMID:25741868 PMID:26467025 PMID:27148439 PMID:28395978 PMID:28492532 PMID:28862987 PMID:29417725 PMID:30814848 PMID:31576961 PMID:31638168 |
|
NCBI chr12:47,407,811...47,433,342
Ensembl chr12:47,407,811...47,433,342
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
|
ISO |
xenograph of human clear cell renal cancer cells in mouse |
RGD |
PMID:19509240 |
RGD:7242921 |
NCBI chr 1:128,924,921...129,213,816
Ensembl chr 1:128,924,966...129,206,516
|
|
G |
Kat8 |
lysine acetyltransferase 8 |
|
ISO |
mRNA, protein:decreased expression:kidney (human) |
RGD |
PMID:23394073 |
RGD:9586034 |
NCBI chr 1:199,360,645...199,372,925
Ensembl chr 1:199,360,645...199,372,923
|
|
G |
Mmp12 |
matrix metallopeptidase 12 |
|
ISO |
|
RGD |
PMID:11576837 |
RGD:2290421 |
NCBI chr 8:5,594,717...5,616,494
Ensembl chr 8:5,606,592...5,616,493
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
susceptibility severity |
ISO |
DNA:transition, transversion:cds:g.677C>T, g.1298A>C (human) |
RGD |
PMID:21489764, PMID:20039875 |
RGD:6893474, RGD:6893632 |
NCBI chr 5:164,844,642...164,864,360
Ensembl chr 5:164,845,925...164,860,910
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
severity |
ISO |
protein:increased expression:kidney (human) |
RGD |
PMID:21881486 |
RGD:7207420 |
NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
ISO |
ClinVar Annotator: match by term: Clear cell carcinoma of kidney |
ClinVar |
PMID:10987279 |
|
NCBI chr 4:145,282,828...145,289,367
Ensembl chr 4:145,282,797...145,289,326
|
|
G |
Pak4 |
p21 (RAC1) activated kinase 4 |
disease_progression |
ISO |
|
RGD |
PMID:25744653 |
RGD:13504816 |
NCBI chr 1:85,162,462...85,201,746
Ensembl chr 1:85,162,452...85,201,757
|
|
G |
Pak6 |
p21 (RAC1) activated kinase 6 |
disease_progression |
ISO |
|
RGD |
PMID:24715215 |
RGD:13506722 |
NCBI chr 3:110,442,175...110,486,317
Ensembl chr 3:110,442,637...110,487,526
|
|
G |
Pbrm1 |
polybromo 1 |
|
ISO |
ClinVar Annotator: match by term: Clear cell carcinoma of kidney |
ClinVar |
PMID:25911086 |
|
NCBI chr16:7,103,714...7,202,899
Ensembl chr16:7,103,998...7,200,362
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
disease_progression |
ISO |
|
RGD |
PMID:25766258, PMID:23879920 |
RGD:13504817, RGD:13506650 |
NCBI chr 7:121,215,458...121,233,092
Ensembl chr 7:121,214,628...121,232,741
|
|
G |
Pml |
PML nuclear body scaffold |
|
ISO |
protein:decreased expression:kidney (human) |
RGD |
PMID:25293974 |
RGD:41404694 |
NCBI chr 8:63,002,515...63,034,310
Ensembl chr 8:63,004,870...63,034,226
|
|
G |
Srsf1 |
serine and arginine rich splicing factor 1 |
|
ISO |
mRNA:altered expression:kidney (human) |
RGD |
PMID:21082031 |
RGD:11039407 |
NCBI chr10:75,334,200...75,341,197
Ensembl chr10:75,335,146...75,341,197
|
|
G |
Srsf2 |
serine and arginine rich splicing factor 2 |
|
ISO |
mRNA:altered expression:kidney (human) |
RGD |
PMID:21082031 |
RGD:11039407 |
NCBI chr10:105,792,779...105,795,986
Ensembl chr10:105,792,779...105,795,958
|
|
G |
Srsf4 |
serine and arginine rich splicing factor 4 |
|
ISO |
mRNA:altered expression:kidney (human) |
RGD |
PMID:21082031 |
RGD:11039407 |
NCBI chr 5:150,032,999...150,060,769
Ensembl chr 5:150,032,999...150,060,765
|
|
G |
Srsf5 |
serine and arginine rich splicing factor 5 |
|
ISO |
mRNA:altered expression:kidney (human) |
RGD |
PMID:21082031 |
RGD:11039407 |
NCBI chr 6:104,611,026...104,640,033
Ensembl chr 6:104,611,026...104,615,302
|
|
G |
Srsf6 |
serine and arginine rich splicing factor 6 |
|
ISO |
mRNA:altered expression:kidney (human) |
RGD |
PMID:21082031 |
RGD:11039407 |
NCBI chr 3:159,305,345...159,310,668
Ensembl chr 3:159,305,345...159,310,668
|
|
G |
Srsf7 |
serine and arginine rich splicing factor 7 |
|
ISO |
mRNA:altered expression:kidney (human) |
RGD |
PMID:21082031 |
RGD:11039407 |
NCBI chr 6:2,879,312...2,886,505
Ensembl chr 6:2,880,518...2,886,465
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
mRNA, protein:increased expression:kidney |
RGD |
PMID:28551630 |
RGD:15036804 |
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25239121 |
|
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
|
|
|
G |
Anxa7 |
annexin A7 |
|
ISO |
protein:decreased expression:colon |
RGD |
PMID:17708571 |
RGD:2292654 |
NCBI chr15:4,254,470...4,281,296
Ensembl chr15:4,254,499...4,281,287
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
IMP ISO |
associated with Adenomatous Polyposis Coli;DNA:point mutation:CDS:p.K1137X (3409A>T) (rat) ClinVar Annotator: match by term: Adenocarcinoma of the colon |
ClinVar |
PMID:24033266 PMID:24728327 PMID:25741868 PMID:27978560 PMID:28492532, PMID:17360473 |
RGD:1601201 |
NCBI chr18:27,011,710...27,106,323
Ensembl chr18:27,047,382...27,105,531
|
|
G |
ApcPirc |
APC, WNT signaling pathway regulator; polyposis in the rat colon |
|
IMP |
associated with Adenomatous Polyposis Coli |
RGD |
PMID:17360473 |
RGD:1601201 |
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
susceptibility |
ISO |
DNA:frameshift mutation: ; |
RGD |
PMID:9020077 |
RGD:734633 |
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
|
|
G |
Csf2 |
colony stimulating factor 2 |
treatment |
ISO |
|
RGD |
PMID:10830715 |
RGD:10450245 |
NCBI chr10:39,602,089...39,604,070
Ensembl chr10:39,602,089...39,604,070
|
|
G |
Ctnnb1 |
catenin beta 1 |
|
IAGP |
DNA:mutation |
RGD |
PMID:16886601 |
RGD:1599637 |
NCBI chr 8:129,601,511...129,628,378
Ensembl chr 8:129,617,812...129,627,372
|
|
G |
Daxx |
death-domain associated protein |
|
ISO |
protein:decreased expression:colon: |
RGD |
PMID:16569639 |
RGD:9587838 |
NCBI chr20:5,480,103...5,485,962
Ensembl chr20:5,480,103...5,485,926
|
|
G |
Fech |
ferrochelatase |
|
ISO |
mRNA:decreased expression:colon |
RGD |
PMID:28075030 |
RGD:14700888 |
NCBI chr18:59,941,992...59,975,192
Ensembl chr18:59,941,992...59,975,192
|
|
G |
Hmgb1 |
high mobility group box 1 |
|
IEP |
|
RGD |
PMID:20616616 |
RGD:10402080 |
NCBI chr12:7,082,529...7,090,246
Ensembl chr16:37,500,017...37,502,237
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
|
ISO |
|
RGD |
PMID:24691442 |
RGD:13210775 |
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
|
ISO |
|
RGD |
PMID:24691442 |
RGD:13210775 |
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
IEP |
mRNA:decreased expression:colon (rat) |
RGD |
PMID:16886601 |
RGD:1599637 |
NCBI chr 1:209,237,255...209,464,189
Ensembl chr 1:209,237,233...209,464,190
|
|
G |
Mir155 |
microRNA 155 |
treatment |
ISO |
|
RGD |
PMID:29535520 |
RGD:21409754 |
NCBI chr11:24,176,603...24,176,667
Ensembl chr11:24,176,603...24,176,667
|
|
G |
Msh6 |
mutS homolog 6 |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of the colon |
ClinVar |
PMID:25741868 |
|
NCBI chr 6:11,644,565...11,662,389
Ensembl chr 6:11,644,578...11,662,499
|
|
G |
Pcsk5 |
proprotein convertase subtilisin/kexin type 5 |
|
ISO |
mRNA:decreased expression:colon: |
RGD |
PMID:19737405 |
RGD:11556207 |
NCBI chr 1:236,031,988...236,313,858
Ensembl chr 1:236,031,988...236,313,858
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
ISO |
DNA:mutation |
RGD |
PMID:17575153 |
RGD:5685670 |
NCBI chr 2:118,831,350...118,861,456
Ensembl chr 2:118,831,350...118,861,454
|
|
G |
Pik3r3 |
phosphoinositide-3-kinase regulatory subunit 3 |
treatment |
ISO |
|
RGD |
PMID:24632606 |
RGD:13432053 |
NCBI chr 5:135,069,972...135,145,633
Ensembl chr 5:135,074,297...135,142,488
|
|
G |
Rac1 |
Rac family small GTPase 1 |
treatment |
ISO |
mRNA:alternative form |
RGD |
PMID:10597294, PMID:19561401 |
RGD:13432049, RGD:13432051 |
NCBI chr12:13,090,316...13,111,841
Ensembl chr12:13,090,172...13,111,873
|
|
G |
Rad54l |
RAD54 like |
|
ISO |
ClinVar Annotator: match by synonym: Colonic adenocarcinoma |
ClinVar |
PMID:10362365 |
|
NCBI chr 5:134,948,511...134,978,125
Ensembl chr 5:134,948,512...134,978,125
|
|
G |
Rnasel |
ribonuclease L |
severity |
ISO |
|
RGD |
PMID:23567782 |
RGD:40902808 |
NCBI chr13:71,188,712...71,202,636
Ensembl chr13:71,192,142...71,202,625
|
|
G |
Srsf4 |
serine and arginine rich splicing factor 4 |
|
ISO |
mRNA:decreased expression:colon mucosa (human) |
RGD |
PMID:9865741 |
RGD:11039405 |
NCBI chr 5:150,032,999...150,060,769
Ensembl chr 5:150,032,999...150,060,765
|
|
G |
Srsf5 |
serine and arginine rich splicing factor 5 |
|
ISO |
mRNA:decreased expression:colon mucosa (human) |
RGD |
PMID:9865741 |
RGD:11039405 |
NCBI chr 6:104,611,026...104,640,033
Ensembl chr 6:104,611,026...104,615,302
|
|
G |
Srsf6 |
serine and arginine rich splicing factor 6 |
|
ISO |
mRNA:decreased expression:colon mucosa (human) |
RGD |
PMID:9865741 |
RGD:11039405 |
NCBI chr 3:159,305,345...159,310,668
Ensembl chr 3:159,305,345...159,310,668
|
|
G |
Tert |
telomerase reverse transcriptase |
treatment |
ISO |
|
RGD |
PMID:19903903 |
RGD:11038656 |
NCBI chr 1:32,250,876...32,275,330
Ensembl chr 1:32,251,714...32,272,476
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
disease_progression |
ISO |
|
RGD |
PMID:9019169 |
RGD:13432089 |
NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
|
|
G |
Vegfc |
vascular endothelial growth factor C |
|
IEP |
mRNA:increased expression:colon |
RGD |
PMID:18424890 |
RGD:2315488 |
NCBI chr16:40,440,371...40,555,178
Ensembl chr16:40,440,207...40,555,576
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
susceptibility |
ISO |
DNA:polymorphism: :3435C>T (human) |
RGD |
PMID:16107775 |
RGD:2312343 |
NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
|
|
G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
IDA |
|
RGD |
PMID:16619498 |
RGD:1598563 |
NCBI chr 4:22,225,123...22,307,577
Ensembl chr 4:22,133,521...22,425,515
|
|
G |
Arpc2 |
actin related protein 2/3 complex, subunit 2 |
|
ISO |
mRNA:decreased expression:colonic mucosa (human) |
RGD |
PMID:25107436 |
RGD:11049173 |
NCBI chr 9:81,518,163...81,548,871
Ensembl chr 9:81,518,176...81,548,871
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
|
ISO |
protein:increased expression:colonic mucosa (human) |
RGD |
PMID:8625322 |
RGD:11353854 |
NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810
|
|
G |
Bcl2l2 |
Bcl2-like 2 |
disease_progression |
ISO |
|
RGD |
PMID:10638987 |
RGD:14394422 |
NCBI chr15:33,543,774...33,549,165
Ensembl chr15:33,544,312...33,549,164
|
|
G |
Birc7 |
baculoviral IAP repeat-containing 7 |
|
ISO |
|
RGD |
PMID:21122381 |
RGD:13217408 |
NCBI chr 3:176,438,335...176,443,864
Ensembl chr 3:176,439,199...176,443,195
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
disease_progression |
ISO |
|
RGD |
PMID:24500602 |
RGD:11567230 |
NCBI chr 4:67,389,331...67,520,549
Ensembl chr 4:67,396,192...67,520,356
|
|
G |
Brd8 |
bromodomain containing 8 |
disease_progression |
IEP |
|
RGD |
PMID:19787264 |
RGD:9587763 |
NCBI chr18:27,375,645...27,423,989
Ensembl chr18:27,398,688...27,424,090
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
disease_progression |
ISO |
mRNA, protein:splice variant, increased expression:large intestine |
RGD |
PMID:16425351 |
RGD:2289356 |
NCBI chr 3:92,695,083...92,783,820
Ensembl chr 3:92,696,313...92,783,658
|
|
G |
Dnmt3b |
DNA methyltransferase 3 beta |
susceptibility |
ISO |
DNA:SNP: : 39179G>T(human) |
RGD |
PMID:19626461 |
RGD:9589082 |
NCBI chr 3:149,131,541...149,170,061
Ensembl chr 3:149,131,785...149,208,786
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
|
RGD |
PMID:8264230 |
RGD:13210753 |
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
|
|
G |
Gata6 |
GATA binding protein 6 |
severity |
ISO |
human cells in a mouse model |
RGD |
PMID:24452072 |
RGD:13208874 |
NCBI chr18:2,415,821...2,447,087
Ensembl chr18:2,416,552...2,446,338
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
ISO |
|
RGD |
PMID:21609933 |
RGD:13210767 |
NCBI chr11:65,060,884...65,208,842
Ensembl chr11:65,066,235...65,209,268
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
|
ISO |
|
RGD |
PMID:12421502 |
RGD:14700996 |
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
onset |
ISO |
|
RGD |
PMID:12421502, PMID:12682546 |
RGD:14700996, RGD:14701003 |
NCBI chr20:13,799,102...13,816,527
Ensembl chr20:13,799,102...13,816,526
|
|
G |
Hpca |
hippocalcin |
severity |
ISO |
mRNA, protein:increased expression:colon carcinoma (human) |
RGD |
PMID:22696308 |
RGD:9693683 |
NCBI chr 5:147,295,124...147,305,757
Ensembl chr 5:147,294,820...147,303,346
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
|
RGD |
PMID:8264230 |
RGD:13210753 |
NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
|
|
G |
Kcnh1 |
potassium voltage-gated channel subfamily H member 1 |
severity |
ISO |
DNA:amplification: (human) |
RGD |
PMID:17289873 |
RGD:9693694 |
NCBI chr13:110,920,712...111,232,291
Ensembl chr13:110,920,737...111,232,269
|
|
G |
Kmt2b |
lysine methyltransferase 2B |
|
ISO |
human gene in a mouse model |
RGD |
PMID:22713656 |
RGD:9588601 |
NCBI chr 1:89,022,889...89,042,176
Ensembl chr 1:89,023,200...89,042,176
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
treatment |
ISO |
|
RGD |
PMID:25405740 |
RGD:13210782 |
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
treatment |
ISO |
|
RGD |
PMID:25405740 |
RGD:13210782 |
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
ISO |
|
RGD |
PMID:21122381 |
RGD:13217408 |
NCBI chr16:9,620,854...9,709,342
Ensembl chr16:9,625,177...9,709,347
|
|
G |
Raf1 |
Raf-1 proto-oncogene, serine/threonine kinase |
|
ISO |
|
RGD |
PMID:21122381 |
RGD:13217408 |
NCBI chr 4:147,532,040...147,592,769
Ensembl chr 4:147,532,042...147,592,699
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
|
RGD |
PMID:8264230 |
RGD:13210753 |
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
G |
Tyms |
thymidylate synthetase |
|
IEP |
protein:increased activity:colon (rat) |
RGD |
PMID:10226549 |
RGD:2317418 |
NCBI chr 9:121,918,875...121,931,564
Ensembl chr 9:121,918,947...121,931,564
|
|
G |
Utp23 |
UTP23, small subunit processome component |
susceptibility |
ISO |
DNA:missense mutation:cds:p.P215Q (rs16888728) (human) |
RGD |
PMID:26553438 |
RGD:11041896 |
NCBI chr 7:91,384,329...91,389,605
Ensembl chr 7:91,384,187...91,389,598
|
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
severity |
ISO |
DNA:mutations:multiple: |
RGD |
PMID:22522847 |
RGD:14402410 |
NCBI chr 2:118,831,350...118,861,456
Ensembl chr 2:118,831,350...118,861,454
|
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8389152 |
|
NCBI chr17:35,907,102...35,958,136
Ensembl chr17:35,907,108...35,958,077
|
|
G |
Bcar1 |
BCAR1 scaffold protein, Cas family member |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29295717 |
|
NCBI chr19:43,932,543...43,967,452
Ensembl chr19:43,932,554...43,955,783
|
|
G |
Ca9 |
carbonic anhydrase 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20526721 |
|
NCBI chr 5:59,008,277...59,015,535
Ensembl chr 5:59,008,933...59,015,528
|
|
G |
Cdh1 |
cadherin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29295717 |
|
NCBI chr19:38,768,467...38,838,395
Ensembl chr19:38,768,467...38,838,395
|
|
G |
Foxa1 |
forkhead box A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29295717 |
|
NCBI chr 6:78,516,579...78,549,669
Ensembl chr 6:78,545,804...78,549,669
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20526721 |
|
NCBI chr 6:96,810,868...96,856,303
Ensembl chr 6:96,810,907...96,856,052
|
|
G |
Hsp90aa1 |
heat shock protein 90 alpha family class A member 1 |
|
IDA |
|
RGD |
PMID:19322027 |
RGD:5686847 |
NCBI chr 6:135,107,262...135,112,793
Ensembl chr 6:135,107,271...135,112,775
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29295717 |
|
NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29295717 |
|
NCBI chr 1:251,421,814...251,487,634
Ensembl chr 1:251,421,596...251,487,832
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20526721 |
|
NCBI chr 5:138,154,677...138,182,897
Ensembl chr 5:138,154,673...138,182,897
|
|
G |
Spop |
speckle type BTB/POZ protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29295717 |
|
NCBI chr10:83,231,187...83,311,987
Ensembl chr10:83,231,238...83,311,592
|
|
G |
Stat5a |
signal transducer and activator of transcription 5A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15609129 |
|
NCBI chr10:88,764,732...88,789,060
Ensembl chr10:88,764,732...88,789,057
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29295717 |
|
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
|
ISO |
protein:increased expression:myoepithelial cells: |
RGD |
PMID:16735089 |
RGD:10053629 |
NCBI chr17:69,761,126...69,778,021
Ensembl chr17:69,761,118...69,778,021
|
|
G |
Ang |
angiogenin |
|
ISO |
protein:increased expression:breast |
RGD |
PMID:15776477 |
RGD:2325702 |
NCBI chr15:28,022,926...28,028,636
|
|
G |
Anxa1 |
annexin A1 |
|
ISO |
protein:decreased expression:mammary gland |
RGD |
PMID:22323911 |
RGD:7421537 |
NCBI chr 1:237,893,983...237,910,002
Ensembl chr 1:237,893,966...237,910,012
|
|
G |
Ar |
androgen receptor |
|
ISO |
|
RGD |
PMID:17543076 |
RGD:1643341 |
NCBI chr X:67,656,253...67,828,998
Ensembl chr X:67,656,253...67,829,026
|
|
G |
Areg |
amphiregulin |
|
ISO |
protein:increased expression:breast |
RGD |
PMID:8543395 |
RGD:2292664 |
NCBI chr14:18,521,921...18,531,179
Ensembl chr14:18,521,930...18,531,179
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
disease_progression |
ISO |
|
RGD |
PMID:12628841 |
RGD:2289659 |
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
disease_progression |
ISO |
protein:increased expression:breast |
RGD |
PMID:16421596 |
RGD:2293106 |
NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
|
ISO |
|
RGD |
PMID:14648660 |
RGD:7483575 |
NCBI chr 1:211,248,098...211,265,282
Ensembl chr 1:211,248,098...211,265,282
|
|
G |
Brca2 |
BRCA2, DNA repair associated |
onset |
ISO |
DNA:missense mutation: :5972C>T |
RGD |
PMID:16280055 |
RGD:2289048 |
NCBI chr12:503,660...544,754
Ensembl chr12:504,007...544,748
|
|
G |
Ca9 |
carbonic anhydrase 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20526721 |
|
NCBI chr 5:59,008,277...59,015,535
Ensembl chr 5:59,008,933...59,015,528
|
|
G |
Casp6 |
caspase 6 |
|
ISO |
protein:increased expression:breast |
RGD |
PMID:10574243 |
RGD:2301339 |
NCBI chr 2:235,341,326...235,353,715
Ensembl chr 2:235,341,365...235,353,967 Ensembl chr 2:235,341,365...235,353,967
|
|
G |
Ccnd1 |
cyclin D1 |
|
ISO |
protein:decreased expression:breast |
RGD |
PMID:14612904 |
RGD:2289132 |
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
|
|
G |
Ccnd2 |
cyclin D2 |
|
ISO |
DNA:hypermethylation:promoter, breast |
RGD |
PMID:14601057 |
RGD:2289156 |
NCBI chr 4:159,674,885...159,697,207
Ensembl chr 4:159,674,885...159,697,207
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
disease_progression |
ISO |
protein:increased expression:breast |
RGD |
PMID:12628841 |
RGD:2289659 |
NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
disease_progression |
ISO |
protein:increased expression:breast |
RGD |
PMID:15788662, PMID:17119686 |
RGD:2289981, RGD:2289931 |
NCBI chr10:86,367,596...86,391,728
Ensembl chr10:86,367,596...86,391,728
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
|
ISO |
|
RGD |
PMID:9470844 |
RGD:2289952 |
NCBI chr 7:2,989,202...3,010,610
Ensembl chr 7:2,989,340...3,010,350
|
|
G |
Erbb4 |
erb-b2 receptor tyrosine kinase 4 |
disease_progression |
ISO |
|
RGD |
PMID:15788662 |
RGD:2289981 |
NCBI chr 9:75,021,790...76,178,936
Ensembl chr 9:75,021,790...75,528,644
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
|
ISO |
associated with Carcinoma, Ductal, Breast |
RGD |
PMID:15841074 |
RGD:2289965 |
NCBI chr12:9,033,993...9,205,886
Ensembl chr12:9,034,308...9,205,905
|
|
G |
Fosl1 |
FOS like 1, AP-1 transcription factor subunit |
|
ISO |
mRNA, protein:increased expression:breast |
RGD |
PMID:17254320 |
RGD:2293756 |
NCBI chr 1:220,826,560...220,835,066
Ensembl chr 1:220,826,560...220,835,066
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
|
ISO |
protein:altered localization:nucleus CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20526721, PMID:16080559 |
RGD:2306227 |
NCBI chr 6:96,810,868...96,856,303
Ensembl chr 6:96,810,907...96,856,052
|
|
G |
Hoxb13 |
homeo box B13 |
|
ISO |
DNA:hypermethylation |
RGD |
PMID:19250546 |
RGD:2314726 |
NCBI chr10:84,031,955...84,034,228
Ensembl chr10:84,031,955...84,034,228
|
|
G |
Klk10 |
kallikrein related-peptidase 10 |
disease_progression |
ISO |
mRNA:decreased expression:breast |
RGD |
PMID:12788170 |
RGD:2314849 |
NCBI chr 1:99,718,275...99,722,743
Ensembl chr 1:99,718,907...99,722,284
|
|
G |
Ldhb |
lactate dehydrogenase B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23437403 |
|
NCBI chr 4:176,701,980...176,719,999
Ensembl chr 4:176,701,983...176,720,012
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
ISO |
protein:increased expression:breast |
RGD |
PMID:17642161 |
RGD:2290392 |
NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased expression:breast |
RGD |
PMID:14744773 |
RGD:2290436 |
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
|
|
G |
Notch4 |
notch receptor 4 |
|
ISO |
|
RGD |
PMID:17440163 |
RGD:2299156 |
NCBI chr20:4,329,794...4,353,868
Ensembl chr20:4,329,811...4,353,785
|
|
G |
Pak2 |
p21 (RAC1) activated kinase 2 |
|
ISO |
|
RGD |
PMID:22886747 |
RGD:7775026 |
NCBI chr11:72,829,407...72,865,815
Ensembl chr11:72,829,238...72,865,902
|
|
G |
Pgr |
progesterone receptor |
disease_progression |
ISO |
|
RGD |
PMID:12628841 |
RGD:2289659 |
NCBI chr 8:7,128,656...7,187,796
Ensembl chr 8:7,128,656...7,187,796
|
|
G |
Prkca |
protein kinase C, alpha |
|
ISO |
protein:decreased expression:breast |
RGD |
PMID:15454252 |
RGD:2292458 |
NCBI chr10:96,186,509...96,585,168
Ensembl chr10:96,191,133...96,584,947
|
|
G |
Ptges |
prostaglandin E synthase |
|
ISO |
protein:increased expression:breast |
RGD |
PMID:16353170 |
RGD:2300083 |
NCBI chr 3:9,727,408...9,738,752
Ensembl chr 3:9,727,408...9,738,752
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
disease_progression |
ISO |
mRNA, protein:decreased expression:breast |
RGD |
PMID:18199541, PMID:18237383 |
RGD:2300203, RGD:2300199 |
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
|
|
G |
Ptk2 |
protein tyrosine kinase 2 |
|
ISO |
protein:increased expression:breast |
RGD |
PMID:15564794 |
RGD:2292561 |
NCBI chr 7:114,436,419...114,611,317
Ensembl chr 7:114,437,361...114,590,119
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
|
ISO |
mRNA, protein:decreased expression:breast |
RGD |
PMID:15312366 |
RGD:2299890 |
NCBI chr15:55,081,582...55,209,060
Ensembl chr15:55,083,140...55,209,342
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
|
ISO |
DNA:amplification |
RGD |
PMID:17375183 |
RGD:2298754 |
NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20526721 |
|
NCBI chr 5:138,154,677...138,182,897
Ensembl chr 5:138,154,673...138,182,897
|
|
G |
Socs1 |
suppressor of cytokine signaling 1 |
|
ISO |
mRNA:increased expression:breast |
RGD |
PMID:12888825 |
RGD:2298909 |
NCBI chr10:4,956,795...4,958,472
Ensembl chr10:4,957,326...4,958,461
|
|
G |
Socs2 |
suppressor of cytokine signaling 2 |
|
ISO |
mRNA:increased expression:breast |
RGD |
PMID:12888825 |
RGD:2298909 |
NCBI chr 7:36,495,496...36,500,878
Ensembl chr 7:36,495,480...36,499,784
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
|
ISO |
mRNA:increased expression:breast |
RGD |
PMID:12888825 |
RGD:2298909 |
NCBI chr10:106,973,863...106,976,969
Ensembl chr10:106,975,178...106,976,040
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
severity |
ISO |
protein:increased activity:breast |
RGD |
PMID:17060931 |
RGD:2315078 |
NCBI chr 3:153,547,807...153,595,643
Ensembl chr 3:153,580,861...153,595,642
|
|
G |
St14 |
ST14 transmembrane serine protease matriptase |
|
ISO |
protein:increased expression:breast |
RGD |
PMID:17163404 |
RGD:2315089 |
NCBI chr 8:32,240,113...32,280,813
Ensembl chr 8:32,240,133...32,280,869
|
|
G |
Stat5a |
signal transducer and activator of transcription 5A |
|
ISO |
protein:altered localization:nucleus CTD Direct Evidence: marker/mechanism protein:decreased expression:breast |
CTD |
PMID:15609129, PMID:15609129, PMID:16133357 |
RGD:2291932, RGD:2291930 |
NCBI chr10:88,764,732...88,789,060
Ensembl chr10:88,764,732...88,789,057
|
|
G |
Tert |
telomerase reverse transcriptase |
|
ISO |
mRNA:decreased expression:breast |
RGD |
PMID:15010825 |
RGD:2291992 |
NCBI chr 1:32,250,876...32,275,330
Ensembl chr 1:32,251,714...32,272,476
|
|
G |
Tff1 |
trefoil factor 1 |
|
ISO |
|
RGD |
PMID:15375487 |
RGD:2292005 |
NCBI chr20:9,892,124...9,895,984
Ensembl chr20:9,892,124...9,895,984
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
ISO |
protein:increased expression:breast |
RGD |
PMID:14744773 |
RGD:2290436 |
NCBI chr10:107,338,465...107,386,072
Ensembl chr10:107,338,465...107,386,072
|
|
G |
Timp4 |
TIMP metallopeptidase inhibitor 4 |
|
ISO |
protein:increased expression:breast |
RGD |
PMID:14744773 |
RGD:2290436 |
NCBI chr 4:147,156,948...147,163,467
Ensembl chr 4:147,156,948...147,163,467
|
|
G |
Top2a |
DNA topoisomerase II alpha |
severity |
ISO |
protein:increased expression:breast |
RGD |
PMID:11070118 |
RGD:2315133 |
NCBI chr10:86,901,467...86,930,947
Ensembl chr10:86,901,007...86,932,154
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
protein:increased expression:breast |
RGD |
PMID:17119686 |
RGD:2289931 |
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
G |
Tymp |
thymidine phosphorylase |
|
ISO |
|
RGD |
PMID:9306962 |
RGD:2293726 |
NCBI chr 7:130,342,481...130,347,845
Ensembl chr 7:130,342,483...130,347,587
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
protein:increased expression:breast |
RGD |
PMID:19623180 |
RGD:2315458 |
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
|
|
|
G |
Men1 |
menin 1 |
|
ISO |
associated with Neuroendocrine Tumors; DNA:loss of heterozygosity: : |
RGD |
PMID:17135306 |
RGD:2317341 |
NCBI chr 1:221,704,394...221,710,343
Ensembl chr 1:221,704,493...221,710,331
|
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO |
ClinVar Annotator: match by term: Duodenal adenocarcinoma |
ClinVar |
PMID:24033266 PMID:25741868 PMID:26530882 PMID:28195569 PMID:28492532 PMID:30111351 PMID:30833958 |
|
NCBI chr18:27,011,710...27,106,323
Ensembl chr18:27,047,382...27,105,531
|
|
|
G |
Angpt1 |
angiopoietin 1 |
|
ISO |
protein:increased expression:endometrium epithelium |
RGD |
PMID:17295646 |
RGD:2293852 |
NCBI chr 7:81,338,327...81,592,459
Ensembl chr 7:81,342,280...81,592,206
|
|
G |
Angpt2 |
angiopoietin 2 |
|
ISO |
protein:increased expression:endometrium epithelium |
RGD |
PMID:17295646 |
RGD:2293852 |
NCBI chr16:75,966,480...76,016,147
Ensembl chr16:75,966,352...76,016,195
|
|
G |
Axin2 |
axin 2 |
|
ISO |
|
RGD |
PMID:11940574 |
RGD:13432156 |
NCBI chr10:97,212,483...97,238,824
Ensembl chr10:97,212,432...97,239,642
|
|
G |
Bet1l |
Bet1 golgi vesicular membrane trafficking protein-like |
disease_progression |
ISO |
|
RGD |
PMID:28654152 |
RGD:14394612 |
NCBI chr 1:213,602,836...213,606,507
Ensembl chr 1:213,602,850...213,605,643
|
|
G |
Cd55 |
CD55 molecule (Cromer blood group) |
|
ISO |
|
RGD |
PMID:11506079 |
RGD:2326173 |
NCBI chr13:47,125,156...47,153,557
Ensembl chr13:47,126,741...47,154,292
|
|
G |
Ebag9 |
estrogen receptor binding site associated, antigen, 9 |
|
ISO |
protein:increased expression:endometrium |
RGD |
PMID:16112719 |
RGD:2289850 |
NCBI chr 7:83,564,563...83,582,516
Ensembl chr 7:83,564,563...83,582,508
|
|
G |
Foxo3 |
forkhead box O3 |
severity |
ISO |
associated with Obesity;protein:decreased expression:endometrium (human) |
RGD |
PMID:26045339 |
RGD:11530998 |
NCBI chr20:46,428,078...46,519,156
Ensembl chr20:46,428,124...46,519,144
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
|
IEP |
mRNA:decreased expression:endometrium (rat) |
RGD |
PMID:19426485 |
RGD:2312621 |
NCBI chr10:40,247,436...40,255,423
Ensembl chr10:40,247,436...40,255,422
|
|
G |
Irf1 |
interferon regulatory factor 1 |
|
IAGP |
DNA:deletions (rat) |
RGD |
PMID:19075038 |
RGD:5128782 |
NCBI chr10:39,109,530...39,116,532
Ensembl chr10:39,109,522...39,116,531
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
no_association |
ISO |
|
RGD |
PMID:10684716 |
RGD:2290482 |
NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
|
IAGP |
DNA:point mutation:CDS:p.G12D, p.G12S, p.Q61H (rat) |
RGD |
PMID:10775052 |
RGD:1600499 |
NCBI chr 4:179,482,562...179,515,483
Ensembl chr 4:179,486,105...179,515,558
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
treatment |
ISO |
human tumor in a mouse model protein:decreased phosphorylation:endometrium (human) |
RGD |
PMID:23402905, PMID:14760076 |
RGD:13703125, RGD:13703137 |
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
treatment |
ISO |
human tumor in a mouse model protein:decreased phosphorylation:endometrium (human) |
RGD |
PMID:23402905, PMID:14760076 |
RGD:13703125, RGD:13703137 |
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
|
ISO |
DNA:mutations:multiple (human) |
RGD |
PMID:21478295 |
RGD:13441595 |
NCBI chr 2:31,742,326...31,826,882
Ensembl chr 2:31,745,088...31,826,867
|
|
G |
Ptges |
prostaglandin E synthase |
|
ISO |
protein:increased expression:endometrium |
RGD |
PMID:11592775 |
RGD:2300089 |
NCBI chr 3:9,727,408...9,738,752
Ensembl chr 3:9,727,408...9,738,752
|
|
G |
Rrm2 |
ribonucleotide reductase regulatory subunit M2 |
|
IAGP |
DNA:amplification (rat) |
RGD |
PMID:15942940 |
RGD:2324953 |
NCBI chr 6:43,884,627...43,890,818
Ensembl chr 6:43,884,678...43,889,515
|
|
G |
Tgfbr3 |
transforming growth factor beta receptor 3 |
|
ISO |
mRNA:decreased expression:endometrium |
RGD |
PMID:15745937 |
RGD:1579943 |
NCBI chr14:3,506,416...3,680,508
Ensembl chr14:3,506,339...3,682,545
|
|
G |
Tp53 |
tumor protein p53 |
disease_progression |
ISO |
DNA:missense mutations protein:increased expression:endometrium |
RGD |
PMID:1540970, PMID:1540970 |
RGD:2290541, RGD:2290541 |
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
G |
Tsg101 |
tumor susceptibility 101 |
|
ISO |
mRNA:alternative forms |
RGD |
PMID:10027311 |
RGD:2291854 |
NCBI chr 1:102,941,151...102,971,017
Ensembl chr 1:102,941,231...102,970,950
|
|
|
G |
Brca2 |
BRCA2, DNA repair associated |
susceptibility |
ISO |
DNA:deletion: :6174delT |
RGD |
PMID:16650962 |
RGD:2289045 |
NCBI chr12:503,660...544,754
Ensembl chr12:504,007...544,748
|
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
ISO |
ClinVar Annotator: match by term: Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation |
ClinVar |
PMID:17611497 PMID:18256540 PMID:18392055 PMID:18504432 PMID:18611285 PMID:19418217 PMID:19487299 PMID:19853286 PMID:20233444 PMID:20453058 PMID:21464312 PMID:21512767 PMID:21793738 PMID:22538770 PMID:22610119 PMID:22722201 PMID:22722839 PMID:22980975 PMID:23237847 PMID:23348505 PMID:23700467 PMID:23728071 PMID:23934607 PMID:24190505 PMID:24657128 PMID:25157968 PMID:26619011 PMID:28492532 |
|
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO |
DNA:hypermethylation: (human) |
RGD |
PMID:18570730 |
RGD:13432144 |
NCBI chr18:27,011,710...27,106,323
Ensembl chr18:27,047,382...27,105,531
|
|
G |
Areg |
amphiregulin |
|
ISO |
mRNA, protein:increased expression:endometrium |
RGD |
PMID:16962163 |
RGD:2289950 |
NCBI chr14:18,521,921...18,531,179
Ensembl chr14:18,521,930...18,531,179
|
|
G |
Atp7b |
ATPase copper transporting beta |
disease_progression |
ISO |
protein:increased expression:endometrium |
RGD |
PMID:15790435 |
RGD:2298864 |
NCBI chr16:74,865,516...74,944,935
Ensembl chr16:74,865,516...74,945,286
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
ISO |
protein:increased expression:endometrium |
RGD |
PMID:16803539 |
RGD:2298940 |
NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
|
|
G |
Bmp4 |
bone morphogenetic protein 4 |
|
ISO |
|
RGD |
PMID:12782598 |
RGD:2296026 |
NCBI chr15:20,776,060...20,791,013
Ensembl chr15:20,776,054...20,822,740
|
|
G |
Ca9 |
carbonic anhydrase 9 |
|
ISO |
protein:altered localization:membrane, endometrium |
RGD |
PMID:17452774 |
RGD:2298945 |
NCBI chr 5:59,008,277...59,015,535
Ensembl chr 5:59,008,933...59,015,528
|
|
G |
Ccne1 |
cyclin E1 |
|
ISO |
protein:increased expression:endometrium |
RGD |
PMID:17483252 |
RGD:2289230 |
NCBI chr 1:94,485,830...94,495,112
Ensembl chr 1:94,485,832...94,494,980
|
|
G |
Cdh1 |
cadherin 1 |
|
ISO |
protein:decreased expression:endometrium |
RGD |
PMID:18295959 |
RGD:2296045 |
NCBI chr19:38,768,467...38,838,395
Ensembl chr19:38,768,467...38,838,395
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
severity |
ISO |
|
RGD |
PMID:9673386 |
RGD:2298990 |
NCBI chr 7:3,124,953...3,132,533
Ensembl chr 7:3,124,954...3,132,457
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
ISO |
|
RGD |
PMID:17985331 |
RGD:2299091 |
NCBI chr 4:168,689,043...168,694,159
Ensembl chr 4:168,689,163...168,693,964
|
|
G |
Chek2 |
checkpoint kinase 2 |
susceptibility |
ISO |
|
RGD |
PMID:17164260 |
RGD:2293868 |
NCBI chr12:51,845,574...51,878,098
Ensembl chr12:51,845,796...51,877,624
|
|
G |
Ctnnb1 |
catenin beta 1 |
|
ISO |
DNA:mutations |
RGD |
PMID:17418409 |
RGD:2289817 |
NCBI chr 8:129,601,511...129,628,378
Ensembl chr 8:129,617,812...129,627,372
|
|
G |
Daxx |
death-domain associated protein |
|
ISO |
protein:increased expression:ovary: |
RGD |
PMID:23539629 |
RGD:9587820 |
NCBI chr20:5,480,103...5,485,962
Ensembl chr20:5,480,103...5,485,926
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
|
ISO |
mRNA,protein:increased expression:uterus: |
RGD |
PMID:15721400 |
RGD:9588596 |
NCBI chr 8:21,922,515...21,968,495
Ensembl chr 8:21,922,515...21,968,495
|
|
G |
Dnmt3b |
DNA methyltransferase 3 beta |
|
ISO |
mRNA,protein:increased expression:uterus: |
RGD |
PMID:15721400 |
RGD:9588596 |
NCBI chr 3:149,131,541...149,170,061
Ensembl chr 3:149,131,785...149,208,786
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO |
mRNA:decreased expression:endometrium ClinVar Annotator: match by term: Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation |
ClinVar |
PMID:22885469, PMID:16962163 |
RGD:2289950 |
NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
|
|
G |
Eno2 |
enolase 2 |
|
ISO |
|
RGD |
PMID:18156975 |
RGD:2293737 |
NCBI chr 4:157,285,192...157,294,090
Ensembl chr 4:157,285,179...157,294,047
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
|
ISO |
|
RGD |
PMID:16962163 |
RGD:2289950 |
NCBI chr10:86,367,596...86,391,728
Ensembl chr10:86,367,596...86,391,728
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
|
ISO |
|
RGD |
PMID:16962163 |
RGD:2289950 |
NCBI chr 7:2,989,202...3,010,610
Ensembl chr 7:2,989,340...3,010,350
|
|
G |
Erbb4 |
erb-b2 receptor tyrosine kinase 4 |
|
ISO |
|
RGD |
PMID:16962163 |
RGD:2289950 |
NCBI chr 9:75,021,790...76,178,936
Ensembl chr 9:75,021,790...75,528,644
|
|
G |
Esr1 |
estrogen receptor 1 |
severity |
ISO |
protein:increased phosphorylation |
RGD |
PMID:14559803 |
RGD:4105451 |
NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
ISO |
ClinVar Annotator: match by term: Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation |
ClinVar |
PMID:7719344 PMID:8651276 PMID:9462761 PMID:9719378 PMID:10851026 PMID:11121055 PMID:11390973 PMID:12124745 PMID:14499350 PMID:15975938 PMID:16440883 PMID:17525745 PMID:18552176 PMID:20301628 PMID:21367659 PMID:22238366 PMID:22664175 PMID:23002168 PMID:23495007 PMID:23546041 PMID:23908597 PMID:24489893 PMID:25157968 PMID:25741868 PMID:25867380 PMID:26380986 PMID:26619011 PMID:28492532 PMID:31145570, PMID:17525745 |
RGD:2289862 |
NCBI chr 1:200,590,951...200,696,946
Ensembl chr 1:200,590,953...200,696,928
|
|
G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
disease_progression |
ISO |
|
RGD |
PMID:17952116 |
RGD:2301465 |
NCBI chr14:87,457,647...87,465,374
Ensembl chr14:87,457,647...87,465,374
|
|
G |
Inha |
inhibin subunit alpha |
|
ISO |
|
RGD |
PMID:17143484 |
RGD:2290368 |
NCBI chr 9:82,700,482...82,703,383
Ensembl chr 9:82,700,468...82,703,400
|
|
G |
Inhba |
inhibin subunit beta A |
|
ISO |
protein:decreased expression:endometrium |
RGD |
PMID:16423381 |
RGD:2301688 |
NCBI chr17:51,894,869...51,919,998
Ensembl chr17:51,898,217...51,912,496
|
|
G |
Kdr |
kinase insert domain receptor |
severity |
ISO |
|
RGD |
PMID:16557278 |
RGD:2291929 |
NCBI chr14:34,727,677...34,787,127
Ensembl chr14:34,727,623...34,787,183
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
|
ISO |
associated with Ovarian Neoplasms |
RGD |
PMID:19542870 |
RGD:2314910 |
NCBI chr 4:179,482,562...179,515,483
Ensembl chr 4:179,486,105...179,515,558
|
|
G |
Lnpep |
leucyl and cystinyl aminopeptidase |
|
ISO |
associated with Endometrial Neoplasms |
RGD |
PMID:15218296 |
RGD:2314922 |
NCBI chr 1:59,289,392...59,384,540
Ensembl chr 1:59,297,294...59,347,472 Ensembl chr 1:59,297,294...59,347,472
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
treatment |
ISO |
|
RGD |
PMID:24917306 |
RGD:13441559 |
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
treatment |
ISO |
|
RGD |
PMID:24917306 |
RGD:13441559 |
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
|
|
G |
Msln |
mesothelin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14576474 |
|
NCBI chr10:15,119,700...15,129,129
Ensembl chr10:15,119,663...15,125,408
|
|
G |
Nkx2-1 |
NK2 homeobox 1 |
|
ISO |
DNA:hypermethylation |
RGD |
PMID:17504987 |
RGD:2290483 |
NCBI chr 6:77,418,096...77,423,383
Ensembl chr 6:77,418,096...77,421,286
|
|
G |
Pdgfra |
platelet derived growth factor receptor alpha |
|
ISO |
protein:decreased expression:ovary |
RGD |
PMID:15791568 |
RGD:2298578 |
NCBI chr14:35,527,926...35,581,130
Ensembl chr14:35,527,927...35,581,031
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
|
ISO |
protein:increased expression:ovary |
RGD |
PMID:15791568 |
RGD:2298578 |
NCBI chr18:56,364,586...56,406,381
Ensembl chr18:56,364,620...56,406,381
|
|
G |
Pik3r2 |
phosphoinositide-3-kinase regulatory subunit 2 |
|
ISO |
ClinVar Annotator: match by term: Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation |
ClinVar |
PMID:21984976 |
|
NCBI chr16:20,415,109...20,424,982
Ensembl chr16:20,416,432...20,424,980
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
DNA:mutations: :multiple DNA:loss of heterozygosity, mutations:multiple (human) |
RGD |
PMID:17418409, PMID:11156411 |
RGD:2289817, RGD:12802357 |
NCBI chr 1:251,421,814...251,487,634
Ensembl chr 1:251,421,596...251,487,832
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
ISO |
|
RGD |
PMID:16633066 |
RGD:1581360 |
NCBI chr14:6,673,686...6,679,965
Ensembl chr14:6,673,686...6,679,901
|
|
G |
St14 |
ST14 transmembrane serine protease matriptase |
|
ISO |
associated with Ovarian Neoplasms;protein:increased expression:ovary |
RGD |
PMID:16439987 |
RGD:2315091 |
NCBI chr 8:32,240,113...32,280,813
Ensembl chr 8:32,240,133...32,280,869
|
|
G |
Wif1 |
Wnt inhibitory factor 1 |
|
ISO |
mRNA:increased expression:ovary |
RGD |
PMID:16436637 |
RGD:2298535 |
NCBI chr 7:63,094,955...63,165,158
Ensembl chr 7:63,094,911...63,165,159
|
|
|
G |
Arid1a |
AT-rich interaction domain 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23525077 |
|
NCBI chr 5:151,904,687...151,977,973
Ensembl chr 5:151,904,684...151,977,636
|
|
G |
Barx1 |
BARX homeobox 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24121790 |
|
NCBI chr17:14,824,721...14,828,196
Ensembl chr17:14,824,734...14,828,329
|
|
G |
Becn1 |
beclin 1 |
|
IEP |
|
RGD |
PMID:22301112 |
RGD:11561943 |
NCBI chr10:89,209,944...89,225,297
Ensembl chr10:89,209,940...89,225,297
|
|
G |
Cdc5l |
cell division cycle 5-like |
disease_progression |
ISO |
protein:increased expression:esophageal mucosa (human) |
RGD |
PMID:15725809 |
RGD:10047052 |
NCBI chr 9:17,949,764...17,988,514
Ensembl chr 9:17,949,764...17,988,509
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23525077 |
|
NCBI chr 5:107,823,323...107,832,405
Ensembl chr 5:107,823,330...107,841,175
|
|
G |
Crtc1 |
CREB regulated transcription coactivator 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24121790 |
|
NCBI chr16:20,740,746...20,798,145
Ensembl chr16:20,740,826...20,794,039
|
|
G |
Ctsb |
cathepsin B |
|
ISO |
|
RGD |
PMID:9770500 |
RGD:734853 |
NCBI chr15:46,316,741...46,337,613
Ensembl chr15:46,316,741...46,337,612
|
|
G |
Dock2 |
dedicator of cytokinesis 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23525077 |
|
NCBI chr10:19,181,512...19,603,171
|
|
G |
Elmo1 |
engulfment and cell motility 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23525077 |
|
NCBI chr17:46,352,102...46,888,788
Ensembl chr17:46,353,330...46,794,845
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
susceptibility |
ISO |
DNA:snps:cds, 3' utr:c.354C>T, c.8092C>A (human) |
RGD |
PMID:18478337 |
RGD:13207314 |
NCBI chr 1:80,256,973...80,268,198
Ensembl chr 1:80,256,973...80,268,198
|
|
G |
Fas |
Fas cell surface death receptor |
|
ISO |
associated with Barrett Esophagus;protein:increased expression:esophageal mucosa (human) |
RGD |
PMID:10340890 |
RGD:8662425 |
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
|
|
G |
Foxp1 |
forkhead box P1 |
|
ISO |
CTD Direct Evidence: marker/mechanism DNA:snps:intron, enhancer:g.70959438A>G, g.70879779A>C (rs9837992, rs2687201) (human) |
CTD |
PMID:24121790, PMID:26383589 |
RGD:11535321 |
NCBI chr 4:131,362,178...131,963,466
Ensembl chr 4:131,366,744...131,694,755
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
|
ISO |
DNA:deletion:: (human) |
RGD |
PMID:17064856 |
RGD:12792242 |
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
|
ISO |
DNA:deletion:: (human) |
RGD |
PMID:17064856 |
RGD:12792242 |
NCBI chr20:13,799,102...13,816,527
Ensembl chr20:13,799,102...13,816,526
|
|
G |
Mir21 |
microRNA 21 |
disease_progression |
ISO |
|
RGD |
PMID:26481465 |
RGD:41404702 |
NCBI chr10:73,902,210...73,902,301
Ensembl chr10:73,902,210...73,902,301
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
susceptibility |
ISO |
DNA:insertion:promoter:g.-1607insG rs1799750 (human) |
RGD |
PMID:19321798 |
RGD:7207058 |
NCBI chr 8:5,703,206...5,723,593
Ensembl chr 8:5,703,206...5,723,591
|
|
G |
Mmp12 |
matrix metallopeptidase 12 |
|
ISO |
DNA:snp:promoter:g.-82A>G rs2276109 (human) |
RGD |
PMID:19321798 |
RGD:7207058 |
NCBI chr 8:5,594,717...5,616,494
Ensembl chr 8:5,606,592...5,616,493
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
|
ISO |
DNA:insertion:promoter:g.-1613insA rs3025058 (human) |
RGD |
PMID:19321798 |
RGD:7207058 |
NCBI chr 8:5,676,608...5,698,579
Ensembl chr 8:5,676,665...5,698,579
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased expression:esophagus |
RGD |
PMID:25562781 |
RGD:13204790 |
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
|
|
G |
Nell1 |
neural EGFL like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17452981 |
|
NCBI chr 1:105,348,577...106,218,970
Ensembl chr 1:105,349,069...106,218,958
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23525077 |
|
NCBI chr 2:118,831,350...118,861,456
Ensembl chr 2:118,831,350...118,861,454
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
IEP |
mRNA,protein:increased expression:Esophagus |
RGD |
PMID:22165968 |
RGD:5687745 |
NCBI chr 3:15,560,685...15,582,339
Ensembl chr 3:15,560,712...15,582,344
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism protein: increased expression: esophagus |
CTD |
PMID:12507933, PMID:12055587 |
RGD:13207437 |
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
|
|
G |
Smad4 |
SMAD family member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23525077 PMID:24952744 |
|
NCBI chr18:69,626,682...69,657,373
Ensembl chr18:69,627,757...69,671,199
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
IDA |
|
RGD |
PMID:17785574 |
RGD:2317403 |
NCBI chr 1:47,914,757...47,921,587
Ensembl chr 1:47,914,759...47,921,587
|
|
G |
Spart |
spartin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23525077 |
|
NCBI chr 2:144,522,382...144,548,968
Ensembl chr 2:144,522,072...144,548,917
|
|
G |
Tlr4 |
toll-like receptor 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23525077 |
|
NCBI chr 5:82,587,424...82,601,056
Ensembl chr 5:82,587,420...82,601,052
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23525077 |
|
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
G |
Vdr |
vitamin D receptor |
susceptibility disease_progression |
ISO |
DNA:SNPs,haplotype:exon:rs1989969,rs2238135 (human) DNA:amplication: : |
RGD |
PMID:25910066, PMID:24951052 |
RGD:11055189, RGD:13432070 |
NCBI chr 7:139,344,452...139,394,138
Ensembl chr 7:139,342,063...139,394,166
|
|
|
G |
Ctnnb1 |
catenin beta 1 |
|
ISO |
protein:increased tyrosine phosphorylation:exon: |
RGD |
PMID:19101982 |
RGD:14402052 |
NCBI chr 8:129,601,511...129,628,378
Ensembl chr 8:129,617,812...129,627,372
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
ISO |
protein:increased expression:liver: |
RGD |
PMID:24925055 |
RGD:11055933 |
NCBI chr16:71,265,390...71,319,046
Ensembl chr16:71,266,248...71,319,449
|
|
|
G |
Ace |
angiotensin I converting enzyme |
|
ISO |
DNA:polymorphism: :rs4646994 (human) |
RGD |
PMID:20438364 |
RGD:2325207 |
NCBI chr10:94,170,766...94,213,831
Ensembl chr10:94,170,766...94,187,822
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
|
ISO |
protein:increased expression:gallbladder |
RGD |
PMID:15017593 |
RGD:2722465 |
NCBI chr20:20,576,341...20,591,510
Ensembl chr20:20,576,377...20,591,549
|
|
|
G |
Acvr1 |
activin A receptor type 1 |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of stomach |
ClinVar |
PMID:25326637 PMID:26619011 |
|
NCBI chr 3:44,432,476...44,539,680
Ensembl chr 3:44,432,471...44,522,930
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of stomach |
ClinVar |
PMID:17611497 PMID:18256540 PMID:18392055 PMID:18504432 PMID:18611285 PMID:19418217 PMID:19487299 PMID:19853286 PMID:20233444 PMID:20453058 PMID:21464312 PMID:21512767 PMID:21793738 PMID:22538770 PMID:22610119 PMID:22722201 PMID:22722839 PMID:22980975 PMID:23237847 PMID:23348505 PMID:23700467 PMID:23728071 PMID:23934607 PMID:24190505 PMID:24657128 PMID:25157968 PMID:26619011 PMID:28492532 |
|
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
|
|
G |
Amigo2 |
adhesion molecule with Ig like domain 2 |
|
ISO |
mRNA:increased expression:serosa of stomach (human) |
RGD |
PMID:15107827 |
RGD:13838842 |
NCBI chr 7:138,704,124...138,707,221
Ensembl chr 7:138,704,126...138,707,221
|
|
G |
B2m |
beta-2 microglobulin |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of stomach |
ClinVar |
PMID:26619011 |
|
NCBI chr 3:114,087,287...114,093,311
Ensembl chr 3:114,087,287...114,093,309
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of stomach |
ClinVar |
PMID:12068308 PMID:12198537 PMID:12960123 PMID:14679157 PMID:15035987 PMID:16187918 PMID:19206169 PMID:21639808 PMID:22048237 PMID:22495831 PMID:22663011 PMID:22972589 PMID:24033266 PMID:24451042 PMID:25157968 PMID:26619011 |
|
NCBI chr 4:67,389,331...67,520,549
Ensembl chr 4:67,396,192...67,520,356
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
disease_progression |
ISO |
mRNA, protein:splice variant, increased expression:stomach |
RGD |
PMID:16425351 |
RGD:2289356 |
NCBI chr 3:92,695,083...92,783,820
Ensembl chr 3:92,696,313...92,783,658
|
|
G |
Cdh1 |
cadherin 1 |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of stomach |
ClinVar |
PMID:10896919 PMID:11968083 PMID:12588804 PMID:12944922 PMI | |